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1. INTRODUCTION 
 தற்காத்துத் தற்ககாண்டான் பேணித் தககசான்ற 
கசாற்காத்துச் பசார்விலாள் கேண். 
- திருக்குறள் -அதிகாரம் 6-56(1). 
“We have a vision where women and girls live in dignity, 
       Are healthy, have choices and equal opportunities” 
- Foundation for Women Health Research 
and Development (2). 
Health is state of complete physical mental and social well-being and not merely 
the absence of disease and infirmity. The WHO defines health as “a state of complete 
physical, mental and social well-being and not merely the absence of disease or 
infirmity”. The health status of women includes their mental and social condition as 
affected by prevailing norms and attitudes of society in addition to their biological and 
physiological problems (3). 
“Healthy women healthy world”  
Women health is an example of population health, the health of a specific 
defined population. It has been described as “a patchwork quilt with gaps” (4).  
World will prosper in knowledge and intellect, 
If both men and women are deemed equal. 
- Subramanya Bharathi. 
Women experience of health and disease differ from those of men, due to unique 
biological, social and behavioural conditions. Biological differences vary all the way 
from phenotype to the cellular, and manifest unique risks for the development of ill 
health (5).  
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While both men and women contact various conditions, some health issues 
affect women differently and more commonly. Women bear exclusive health concerns, 
such as, 
➢ Breast cancer 
➢ Cervical cancer 
➢ Menopause 
➢ Pregnancy 
➢ Heart attack 
➢ Depression and anxiety 
➢ Urinary tract infections 
➢ Sexually transmitted diseases 
➢ Osteoporosis 
➢ Thyroid problems 
➢ Systemic lupus erythematosus (6). 
Many women’s health conditions go undiagnosed and most drug trials do not 
include female test subjects. 
Hormone plays vital role in women health. Nowadays Women facing the main 
problem is hormone imbalance. Hormone distrubances are increased with stress and 
then result in Polycystic ovarian disease. Work pressures lead them to eat more of junk 
food which leads to obesity and other health related issues (7).  
Polycystic ovarian disease or syndrome was earlier known as Stein-Leventhal 
syndrome. 1% female population suffers from PCOS, and the patients are mostly 15 to 
25 years of age. PCOS includes chronic non-ovulation and hyperandrogenaemia 
associated with normal or raised oestrogen (E2), Altered LH/FSH ratio (raised LH and 
low FSH ratio) (8). 
PCOS is a heterogeneous endocrine disorder, leading to several health 
complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity and 
metabolic syndrome (9). 
Anti-Mullerian hormone (AMH), also known as Mullerian inhibiting hormone 
(MIH), is a glycoprotein hormone structurally related to inhibin and activin from the 
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transforming growth factor beta superfamily, whose key rules are in growth 
differentiation and folliculogenesis (10).  
Anti-Mullerian hormone (AMH) levels are increased in polycystic ovarian 
syndrome (PCOS), but it is not known whether other forms of hyperandrogenism, such 
as PCOS observed in women with type 1 Diabetes Mellitus (DM1), are also associated 
with elevated AMH levels. 
Causes: Causes of PCOS is unknown. But Doctor’s believe that high levels of male 
hormones prevent the ovaries from producing hormones and making eggs normally. 
Genes, insulin resistance, and inflammation have all been linked to excess androgen 
production (11). 
Prevalence: PCOS is a common female endocrine disorder with prevalence ranging 
from 2.2% to 26%. Most reports have studied adult women with age ranged from 18 to 
45 years. The aim of this study was to find the prevalence of in Indian adolescents. In 
Indian adolescents is 9.3% (12).  
Signs & symptoms: 
➢ Irregular periods 
➢ Poly cystic ovaries 
➢ Hirsutism 
➢ Obesity 
➢ Acne 
➢ Alopecia 
➢ Skin tags 
➢ Acanthosis nigricans 
➢ Infertility (13) 
Pathophysiology: The endocrinologic abnormality of PCOS begins soon after 
menarche. Chronically elevated luteinizing hormone (LH) and insulin resistance are 2 
of the most common endocrine aberrations seen in PCOS. The genetic cause of high 
LH is not known. It is interesting to note that neither an elevation in LH nor insulin 
resistance alone is enough to explain the pathogenesis of PCOS.  
Obesity, which is seen in 50% to 65% of PCOS patients, may increase the 
insulin resistance and hyperinsulinemia. One important caveat is that the correlation 
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between hyperandrogenism and insulin resistance has been recognized in both obese 
and nonobese anovulatory women. Thus, it is important to realize that a nonobese 
patient may also have insulin resistance. 
Regular ovulatory cycles at puberty depends on a complex series of interactions 
involving the hypothalamus, anterior pituitary and ovary (HPO axis) in Polycystic 
ovarian disease normal physiological function are distrubed because of defect in 
hypothalamo pituitary and ovarian axis leads to hormonal imbalance(14). 
Complications: Women with PCOS are more likely to develop certain serious health 
problems. These include type 2 diabetes, high blood pressure, problems with the heart 
and blood vessels and uterine cancer. Women with PCOS often have problems with 
their ability to get pregnant (fertility) (15). 
The American College of Obstetricians and Gynaecologists (ACOG) and 
Society of Obstetricians and Gynaecologists of Canada (SOGC) indicate that lifestyle 
modifications such as weight loss and increased exercise in conjunction with a change 
in diet consistently reduce the risk of diabetes (16). 
Treatment: Typical ways to treat hyperandrogenism include cosmetic procedures 
(specifically for hirsutism), estro-progestins, antiandrogens alone or combined with 
ethinylestradiol and if necessary, insulin sensitizers, particularly metformin. 
Antiandrogens may represent an alternative way to improve both hyperandrogenaemia 
and hirsutism (17). 
Complications of treatment: 
➢ Multiple pregnancy 
➢ Ovarian Hyperstimulation Syndrome (OHS) 
➢ Adhesion formation in surgical procedure(18). 
Siddha system of medicine is enriched with unique and peculiar aspects with 
treasure house of secret science. The meaning of “Siddh” is endless knowledge, hence 
Siddha denotes unlimited knowledge. Another possible explanation is that those who 
achieved perfection are called Siddhars. Since the word Siddhi means achievement of 
perfection. The system of medicine revitalized and rejuvenates the internal organs and 
provide guidelines for healthy lifestyle for healthy living.  
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The Siddhars uniformly believed that a human being is composed of 96 basic 
factors. These 96 factors are which they called as basic “Thathuvas”, these Thathuvas 
are universal to all human beings. 
They classified various female diseases and had amazing solutions for its 
curative measures and also handled with preventive aspects. 
In Siddha system of medicine, numerous single herbals, poly herbal formulation 
is available to treat PCOS. Such as, 
➢ Moosambara mezhugu, 
➢ Lavana chendhooram, 
➢ Sanga thiravagam, 
➢ Kariyuppu parpam,  
➢ Attathi chooranam, 
➢ Saampiranippoo kuzhigai. 
So, I hope that this Siddha system of medicine will cure the PCOS, that’s why 
I prefer to choose the medicine SOODHAGA MEZHUGU. One of the main herbals & 
mineral formulation mentioned for PCOS is “Soodhaga Mezhugu” which contains 
Vengarathool [Sodium biborate], Valendhrapolam [Commiphora myrrha], Kunguma 
poo [Crocus sativus], Kirambu thylum [Syzygium aromaticum] by Ovulation inducing 
activity, Estimation of hormone level, Anti-oxidant activity in animal model. 
Hence, this SOODHAGA MEZHUGU from our treasure of Siddha system of 
medicines would provide the society with a drug that is cost effective, Safe, Promising 
drug for PCOS.  
AIM AND OBJECTIVES 
 
OVULATION INDUCING ACTIVITY OF SOODHAGA MEZHUGU                 6 
 
 
    2. AIM AND OBJECTIVES 
AIM: 
The present study will be focused to validate the PCOS curing efficacy of 
“SOODHAGA MEZHUGU” by Ovulation Inducing Activity, Estimation of Hormone 
Level, Anti-oxidant Activity in animal model. 
OBJECTIVES:  
➢ Collection of relevant literature from Siddha text book at the same time 
compared and collected with modern aspect for present study.  
➢ Systematic identification of drug material through microscopic and 
macroscopic method. 
➢ Detoxification and manufacture of drug material according to the Siddha 
classical literature. 
➢ Standardization of trial drug through the following steps: 
❖ Macroscopic Methods 
❖ Microscopic Methods  
❖ Physical Methods 
❖ Chemical Methods  
❖ Biological Methods 
➢ To analyze physicochemical property of the drug. 
➢ Identifying the presence of acid and basic radicles through biochemical 
analysis.  
➢ Identify the chemical structure of the drug through the Instrumental analysis. 
➢ To determine the toxic effect of trial drug with the help of OECD guideline 
(Acute 423 and Repeated Oral Toxicity 407). 
➢ Pharmacological activity of the trial drug Soodhaga Mezhugu (SM) is proved 
by the following method Ovulation Inducing Activity (Estrodial induced PCOS 
in Female Wistar albino rats), Estimation of Hormone Level (Estrodial induced 
PCOS in Female Wistar albino rats), Anti-oxidant Activity (DPPH assay 
method). 
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3. REVIEW OF LITERATURE   
3.1. DRUG REVIEW 
3.1.1. GUNAPADAM ASPECT 
The following drugs are the ingredients of Soodhaga mezhugu (SM) 
➢ Vengarathool [ Sodium biborate]   
➢ Valendhrapolam [ Commiphora myrrha] 
➢ Kunguma poo [Crocus sativus] 
➢ Kirambu thylum [ Syzygium aromaticum] 
 
1.Vengarathool (Sodium biborate) 
Chemical name: Sodium biborate 
Other name of Vengarathool: 
➢ Porikaram  
➢ Karam  
➢ Urukkinam  
➢ Urukkumithran  
➢ Danganam  
➢ Thoomathaiadakki 
The Borax is roasted in a pan till the moisture completely evaporates. By this 
method of purification, the borax became in purified form and used in the preparation 
of medicine. 
It is one among the type of salt (Kaarasaaram). It comes under synthetic salt 
(Saeiyarkai uppu). Borax is obtained in California abundantly. It is also found in Tibet 
and Nepal. Naturally it is obtained along with sand and dust. 
Properties of Borax: 
➢ Color is white, clear, shining with some angles 
➢ Soluble in water 
➢ Insoluble in alcohol 
➢ Taste is sweet with astringent 
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The Borax available in the shops are not pure. Hence four parts of hot water and 
a small amount of Calcium carbonate(lime) are added to it, filtered, insulated and heated 
till the water evaporates completely. The salt so obtained is pure and can be used. 
If borax expands to air, white powder is deposited on the surface. It is very 
important drug for preparing Parpam, Chendhooram and Guru-Kuligai.   
 Taste  :     Sweet, Astringent. 
 Potency :     Heat 
 Action   
1. Internally:      
❖ Putrefacient 
❖ Diuretic 
❖ Emmenagogue 
❖ Refrigerant 
❖ Lithotripsic 
2. Externally:  
❖ Astringent 
❖ Antiseptic 
❖ Alternative 
❖ Neutralizer 
General character: 
               “காரமென்று இதற்குப்பேர் வந்தது எது 
கட்டுபெ அறுேத்து நாலு தாதும் 
 காரமென்று இதற்குப்பேர் வந்த தாபே 
 கடிசான உேரசநூற் றிரண்டும் சத்தாம் 
 காரமென்று இதற்குப்பேர் வந்தமதன்றால் 
       கட்டாத சாரந்தான் இதற்குள் கட்டும் 
 காரமென்று இதற்குப்பேர் வந்த தாபே 
 களங்குகுரு சிந்தூரத்து ஆதி காபே”. 
    -போகர் ஏழாயிரம் இரண்டாம் காண்டம். 
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Special characters of Vengaram 
“மநளியான உருக்கினத்ததச் மசால்ேக் பகளு 
 பநரான மவண்காரம் ஜவ்வாதுவீர 
 மொளியான மரங்கிட்டால் உருக்கினத்துக்காத” 
  - சட்டமுனி வாத காவியம்.  
➢ It makes 64 paadanam as Kattu 
➢ It makes 120 ubarasam as sathu 
➢ It is important (aathi) for preparing Kalangu, Chendooram and Guru.  
General characters: 
  “மசாறிபுதடமயண் குன்ெநதெ பசாரி யாசம் 
  ேறிகிரகணி கல்லூனம் ேன்பனாய்-மநறிதயத் 
  தடங்கேங்க ேங்கிருமி சர்ப்ேவிடஞ் சந்நி 
  யிடங்கேங்க ேக்கிற்போ மெண்.” 
- குேோடம் தாது சீவம் வகுப்பு. 
Indications: 
➢ It cures Toad skin, Itching, Venereal ulcer with pus and Ulcers on the nipple. 
➢ It is also used to cure Gastric ulcer, Hemorrhoids, Stomatitis, Itching, 
Indigestion. 
➢ Borax is used to cure Amenorrhea, Menorrhagia, Dysmenorrhea, Delayed 
labor. 
➢ Borax is used to cure Hemiplegia and Urinary Tract Infections. 
Purifications: 
➢ Borax is bundled, kept buried in buffalo’s dung for 3 days, then washed and 
dried. 
➢ Borax is soaked in buffalo’s urine for 72 minutes.  
➢ Fried in an earthen pan and triturated with lemon juice or vinegar and dried. 
➢ Roasted in a pan till the moisture completely evaporates. 
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Uses: 
➢ Borax is mixed with water. A cotton cloth is dipped and it’s applied 
externally for wounds. 
➢ Borax with pig ghee applied over the painful anus for anorectal diseases. 
➢ Borax with tender coconut cures urinary tract infection. 
➢ It is mixed with water and used for cleaning the eyes in eye diseases. 
➢ Borax with betel leaf prevents fever with rigor (19). 
Other Preparations from borax: 
❖ Venkaraparpam 
❖ Venkaramathirai 
❖ Venkarakattu 
❖ Vengara mathu: Roasted borax with honey cures glossitis. 
❖ Venkaraneer 
Chooranam 
❖ Deepakini chooranam, 
Maathirai 
❖ Aanantha pairavam 
❖ Emathanda kuligai 
❖ Venkaramathirai 
Chenthooram 
❖ Mandoorachendhooram 
Kuzhambu 
❖ Agasthiyar kuzhambu 
❖ Kumatti kuzhambu 
❖ Gowsigar kuzhambu  
Mezhugu 
❖ Gunmakudori mezhugu 
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2. Valendhrapolam (Commiphora myrrha) 
Botanical Name: Commiphora myrrha  
Other names 
❖ Kunkumadeepam  
❖ Kundhru 
❖ Vellaippolam 
❖ Vellaathirapolam  
❖ Meeru 
Family - Burseraceae  
Vernacular names: 
Eng - Myrrh 
Hin - Bol, Hirable 
Kan - Bola 
Mal - Narumpasamaram, Narumpasa 
San - Bolah, Rasagandhah 
Tam - Vellaippolam 
Tel - Balimtra – Polam 
Habitat:  
➢ A small tree which is the source of Herabol myrrh. 
➢ The gum resin exudate from wounds in the stem is pale yellow at first and 
later solidifies to brown-black.   
Part used  - Gum  
Taste   - Bitter  
Potency  - Heat   
Division - Pungent 
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Action:  
❖ Stimulant 
❖ Expectorant 
❖ Emmenagogue 
❖ Stomachic 
❖ Carminative 
General characters: 
சூலைகய ர ோகம் ச ோறிக ப்போன் குன்ம மிலை 
      ஆலைைோ யிங்ரகோல்ரபோல் ஆகுங்கோண் – நீை க்க  
    ைோளசமனத் ர ோற்றுமுலை மோ  ர ! ைோரைந்தி  
     ரபோளந்  லனசயடுக்கும் ரபோது. 
- அகத்தியர் குேோடம்.  
Indications : Acute pain, Tuberculosis, Pruritis, Eczema, Peptic ulcer(20a). 
Preparation of Myrrh: 
❖ Moosambara mezhugu. 
3.Kunkumapoo (Crocus sativus) 
Other name:  
➢ Kashmiram 
➢ Gnyazhal poo 
Vernacular name: 
 Sanskrit - Bhavarakta, Kumkuma. 
English - Saffron 
 Hindi  - Kumkum, kesar 
 Telugu - Kumkuma-puvvu 
 Malayalam - Kumkumada puvvu. 
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Habitat: 
 An autumnal dwarf herb, a native of Levant in Asia Minor, now cultivated on a 
small scale in Kashmir and around Quetta. 
Parts used: 
 Dried stigmas and tops of the styles of Crocus sativus, which constitute the 
saffron of commerce compressed into cakes and called “cake saffron” the ordinary 
saffron being called Hay saffron. 
Properties and uses: 
 Taste  : Bitter 
 Potency : Heat 
 Division : Pungent 
 Action    
❖ Stimulant 
❖ Stomachic  
❖ Antispasmodic 
❖ Emmenagogue 
General characters: 
 “விந்துநட்டந் தாகெண்டம் பெகசேஞ் சூதேகேம்  
  உந்துசுரம் பித்தங்கால் உச்சிவலி முந்துகண்ணில் 
  தங்குெப்பூ பவாடுறுபநாய் சர்த்தியதவ நீங்கமவன்றால் 
  குங்குெப்பூ ஓரிததழக் மகாள்.” 
       -  அகத்தியர் குேோடம். 
Indications: 
It cures Reduced Sperm Count, Thirst, Diabetes, Neuritis, Kabhasuram, 
Headache, Cataract, Eye related diseases, Vomiting, Ear related diseases, Sinusitis, 
Taste of sweetness in mouth. It also Expels Lochia.  
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Therapeutic Uses: 
➢ It is used generally as a condiment for its aromatic odor and beautiful coloring 
matter. 
➢ Medicinally, it is used in small doses, in fevers, melancholia, enlargement of 
liver and in spasmodic cough and Asthma and in catarrhal affections of children.  
➢ It is given in Anemia, Chlorosis and Seminal debility. 
➢ As a stimulant and Aphrodisiac, it is considered to be a sovereign remedy, not 
to be excelled in virtue by the whole range of drugs in the Materia medica.  
➢ It gives the urine a yellow color.  It is given in Rheumatism and Neuralgia and 
to children with ghee in looseness of the bowels. 
➢ It is given also to relieve flatulent colic, Amenorrhea, Dysmenorrhea, 
Leucorrhoea etc. 
➢ Pessaries of saffron are used in painful Infections of the uterus.  
➢ Externally saffron is used in head ache in the form of paste, also applied to 
bruises and superficial sores. 
➢ It is an excellent palliative for Hemorrhoids. 
➢ Saffron is used in snake bite also(20b). 
Preparation of Saffron: 
Maathirai 
❖ Korosanai maathirai 
❖ Maha elathi kuligai 
❖ Kunguma poo maathirai 
Karuppu 
❖ Kasthoori karuppu 
Mai 
❖ Nandhimai  
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4. Kirambu (Syzygium aromaticum) 
Other names : 
➢ Lavangam  
➢ Anjukam 
➢ Tirili 
➢ Varangam  
➢ Chosam 
Vernacular names 
 Tamil    : Kirambu 
 English  : Cloves, clove tree 
 Sanskrit  : Lavangam 
 Telugu  : Lavangalu 
 Kannadam  : Lavanga 
 Hindi   : Long 
 Malayalam  : Karampu 
Part used: 
 Dried flower buds, fruit and oil. 
Properties and uses:  
 Taste  : Pungent 
 Potency : Heat 
 Division : Pungent 
 Action   
❖ Carminative 
❖ Antispasmodic 
❖ Appetizer 
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Habitat: 
 Clove is a dense and handsome evergreen tree that can grow around 20 meters 
tall. The short bole can be around 25cm in diameter. 
 The plant has been valued as a spice for at least 2,500 years. It is commonly 
cultivated in the tropics, especially southeaster Asia but also Africa and the Americas, 
for its dried, unopened flowers and the essential oil derived from them. 
General characters: 
 “பித்தெயக்கம் பேதிமயாடு வாந்தியும் போம் 
  சுத்தவிரத்தக் கடுப்புந் பதான்றுபொ-மெத்த 
 இேவங்கங் மகாண்ட வருக்பகற் சுகொகும் 
 ெேெங்பக கட்டுமென வாழ்த்து.”  
 “சுக்கிேநட்டங் கர்ேசூர்வியங் கோஞ் சனந்தாட் 
 சிக்கல் விடாச்சர் வாசியப்பிணியு- ெக்கிக்குட் 
 டங்கப்பூ பவாடு தரிேடருந் பதான்றிலில் 
 வங்கப்பூ பவாடு தரத்துவா” 
- அகத்தியர் குேோடம். 
Indications: It cures Giddiness, Diarrhoea, Dysentery, Vomiting, Anal fissure and 
Cataract. 
Therapeutic uses  
➢ Relieve Flatulence, Gastric irritability, Dyspepsia and to Increase the flow of 
saliva 
➢ Given to appease thirst. 
Decoction: 
 It is used for arresting vomiting and curing digestive disorders like indigestion, 
colic, flatulence, dyspepsia etc. 
 It is specially recommended for pregnant women in case of vomiting and 
rumbling noise of the stomach. 
 The oil distilled from this forms and esteemed remedy for tooth-ache(20c). 
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Preparation of Clove: 
 Kirambu thylum 
Maathirai: 
➢ Kunkumapoo maathirai  
➢ Kapada mathirai 
➢ Amurthathi kuligai 
➢ Asta pairava kuligai 
➢ Kalyana vairavam 
Thylum: 
➢ Kirambu thylum 
3.1.2. MODERN ASPECT OF VENKAARAM: 
1. BORAX (வெங்காரம்) (21): 
Other name  : Sodium tetraborate or Disodium tetraborate.  
Chemical Name : Sodium biborate 
 
Fig.No.1. Borax (வெங்காரம்) 
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General properties: 
➢ Chemical formula : Hydrated sodium borate Na2B4O7 -10H2O 
➢ Color   : White powder with soft colorless crystals. 
➢ Weight   : 201.22 g/mole and 
➢ Melting point  : 741 degrees Celsius. 
➢ Boiling point  : 320 Celsius.  
➢ Density   : 1.73. 
➢ The pH   : alkaline. 
➢ Solubility   : 6g to 100g of water. 
➢ Borax is stable and non-corrosive in the presence of glass. 
➢ Source:  
On seashore it dried up in lakes of India and Tibet. It is also found in the 
mud of lakes surrounded by hills of Nepal (22). 
Chemical properties: 
The following are several borates of Sodium  
➢ Sodium tetra borate-Na2B4O710H2O or anhydrous form 
➢ Sodium meta borate-Na2BO4H2O 
➢ Sodium per borate   -NaBO2H2O3H2O 
➢ Sodium Penta borate-Na2B10O1610H2O 
Commonly Sodium tetra borate was used for all kinds of purposes. 
Specific gravity of borax:  1.7 
Character: 
Borax was composed mainly of boric acid and soda. In the native state borax 
was impure saline incrustation of a dirty white in colour. It exists as a crystalline tough 
masses or translucent irregular masses. It was exposed to air becomes opaque in nature. 
The natural colour of borax was greyish-white. 
Purification: 
Roasted in a pan till the moisture completely evaporates. 
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Action: 
❖ Anti-septic  
❖ Diuretic 
❖ Emmenagogue  
❖ Antacid 
❖ Astringent and Local sedative 
Borax has four special centres of action (23), 
➢ Mucous membranes          - Aphthous inflammation 
➢ Sexual organs in women   - Stimulates menstruation 
➢ Skin                                   - Slight injuries suppurate 
➢ Locally                              - Powerful antiseptic and disinfectant.  
Uses of borax: 
External 
Borax was used for disinfectant and antiseptic and it is much more active in 
preventing than in inhibiting decomposition.  
Internal 
➢ They are largely used to keep healing the wounds and ulcers. The action was 
exhibited locally. 
➢ According to Indian Materia medica the Borax was used internally in dose 
varying from 10-30 grains, in acidity of stomach, amenorrhea, dysmenorrheal, 
menorrhagia, puerperal convulsions and to promote uterine pain during labor 
➢ It was taken internally. It is said to relieve irritability of the bladder. 
➢ In rare cases its use has caused either psoriasis, a popular eruption especially 
marked near the elbows, an erythematous rash or eczema. Nausea, loss of 
appetite, vomiting, and diarrhea may be produced. 
➢ Borax has been given in CNS disorder epilepsy. As it has an antiseptic it has 
been given internally in typhoid fever and phthisis, but with less benefit (24). 
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2. MYRRH (ொலேந்திரல ாளம்): 
 
Fig.No.2. Myrrh (ொலேந்திரல ாளம்) 
 
Classification: 
 Kingdom  - Plantae 
 Division  - Magnoliophyta 
 Class   - Magnoliopsida 
 Order   - Sapindales 
 Family   - Burseraceae 
 Genus   - Commiphora 
 Species  - myrrha (25) 
Distribution: 
 Indigenous to North-East Africa especially Somalia Island. Collected in Saudi 
Arabia, Abyssinia, Iran, Thailand and sold in Indian bazars(26a). 
Description: 
The Commiphora species that serve as source of myrrh, are thorny shrubs or 
small trees that grow to up to 3 meters high. A pale yellow-white viscous liquid exudes  
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from natural cracks or fissures in the bark or from fissures cut intentionally to harvest 
the material. When air-dried, these exudates harden into a reddish-brown mass that 
often contains white patches. These tears are approximately the size of a walnut and 
from the basis of myrrh resin. Myrrh is usually collected in the summer months (Leung, 
1980; Evans, 1989; Michi and Cooper, 1991) 
  A small tree which is the source of Herbal myrrh. 
 The gum resin exudate from wounds in the stem is pale yellow at first and later 
solidifies to brown-black. 
Parts used: Gum. 
Chemical Constituents: 
The major constituents of the essential oil identified from the resin of 
Commiphora myrrha were α-elemene (12.86%), 7-isopropyl-1, 4-dimethyl-2-azulenol 
(12.22%), curzerene (11.64%) and germacra-1(10)7, 11-trien-15-oic acid,8,12-epoxy-
6-hydroxy- c-lactone (6.20%). In both DPPH scavenging and Fe2+ chelating assays (27). 
Myrrha is an oleo-gum-resin obtained from the stem of C. molmol (Evans, 
1989; Michi and cooper, 1991). It contains 2% to 10% of a volatile oil composed 
predominantly of sesquiterpenes, sterols, and steroids. Water soluble gum portion 
(30%- 60%) contains polysaccharides and proteins as well as ethanol-soluble resins 
(25%-40%). After undergoing hydrolysis, the gum produces a variety of sugars. 9F 
anesthetic, antibacterial, antifungal, and hypoglycemic effect (Hanus et al, 2005; 8 Zhu 
et al, 2003). When oleo-gum-resin is mixed with water it forms an emulsion (El Ashry 
et al, 2003). 2.2.4. Antimicrobial activity 
Action: 
Myrrh is thought to mediate its anti-inflammatory activity through inducing 
haem oxygenase activity. It appears to produce an analgesic effect associated with its 
suppression of prostaglandin production. Compounds in myrrh bind to and inhibit the 
farnesoid X receptor resulting in a reduction in low density lipoprotein. 
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Properties and uses: 
 The gum is bitter, acrid and astringent, acrid after the process of digestion, 
thermogenic, digestive, carminative, expectorant, intellect promoting, aphrodisiac, 
anthelmintic, anti-inflammatory, diuretic, sudorific, ophthalmic, antiseptic, stimulant 
and tonic, and is useful in vitiated conditions of Vata, Pitta and Kapha, stomatitis, 
dyspepsia, helminthiasis, amenorrhea, dysmenorrhea and other menstrual disorders, 
bronchitis, asthma, phthisis, ophthalmia, spongy gum, pharyngodynia, rheumatoid 
arthritis, sciatica, wounds and ulcers, inflammations, strangury and skin diseases. 
 The herbal myrrh is also used in perfumery, mouth washes, dentifrices and in 
religious ceremonies as incense. This is reported to be used by ancients for 
embalming(26b). 
  Myrrha has been used for centuries as incense (Evans, 1989), and for medicinal 
purposes (Michi and Cooper, 1991), medicinally, it has been used as an astringent, 
antiseptic, anti-parasitic, antitussive, emmenagogue, and antispasmodic agent. It was 
commonly included in mixtures used to treat worm, wounds, sepsis, cough in children, 
skin and mouth infections, and as suppository form to treat proctitis (Michio and 
Cooper, 1991). Myrrh has also been reported to treat gout, headache, jaundice, throat 
ailments indigestion, fatigue, and paralysis (Greene, 1993). It has also been used in 
variety of 9 infectious diseases, including leprosy and syphilis and to treat cancers (El 
Ashry et al, 2003) (27). 
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3. SAFFRON (குங்குமப்பூ ): 
 
Fig.No.3. Saffron (குங்குமப்பூ ) 
Classification: 
 Kingdom - Plantae 
 Class  - Monocots 
 Order  - Asparagales 
 Family  - Iridaceae 
 Sub family - Crocoideae 
 Genus  - Crocus 
 Species - sativus 
Distribution: 
 The plant is a native of south Europe and is cultivated in Spain, France, Italy, 
Greece, Turkey, India and China. 
 Saffron thrives well in cold regions with warm or sub-tropical climate.  It 
requires a rich, well dried sandy or loamy soil.  The plant is propagated vegetative by 
bulbs.  Bulbs once established continue to live for 10 to 15 years (28). 
Description: 
 A small bulbous perennial, 15-25 cm high, leaves radical, narrowly linear, 
channelled, leaf sheaths closely reticulate, flowers blue, scented, appearing with leaves, 
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throat of perianth bearded, anthers yellow, ovary three-celled, stigmas orange coloured, 
trifid on filiform style tops, fruits loculicidal capsules. 
 The saffron of commerce is the dried style tops with orange coloured stigmas.  
Parts used: 
 Dried stigmas and tops of the styles of Crocus sativus, which constitute the 
saffron of commerce compressed into cakes and called “cake saffron” the ordinary 
saffron being called Hay saffron. 
Macroscopic characters: 
 The dried drug consists of loosely matted mass of dark orange-reddish brown 
flattened brittle threads of stigma and upper parts of styles each separated piece shows 
three stigmas attached to a very short or about 1 cm long cylindrical style, the stigma is 
2.5 to 3 cm in length, with a long cylindrical tube, narrow at the base getting slowly 
broader and flattened towards the upper extremities where it slits longitudinally on the 
inner side, the lips of the tube are irregularly notched and the margin is papillose, 
surface is longitudinally striated and occasionally studied with pollen grains. Taste is 
mildly bitter and odour characteristic. 
Microscopic characters: 
 Diagrammatic TS passing through the centre of the flattened stigma is horse-
shoe shaped and shows rows of vascular bundles embedded in the parenchymatous 
mesophyll tissue lying in between the upper and lower epidermis. 
 Detailed TS shows a layer of upper and lower epidermis and 10 to 15 rows of 
parenchymatous mesophyll tissue filled with orange red coloured pigments and 
traversing with conjoint collateral small vascular bundles. 
Powder: 
 Shows transversely cut fragments from the tubular portion of the stigma 
showing epidermis and mesophyll cells filled with orange coloured pigment and 
vascular bundle fragments of the papillose epidermis of the stigma from the apical 
portion in surface view and cut longitudinally large spherical thick-walled pollen grains 
and their broken fragments, scattered as such throughout transversely cut fragments of 
the style showing papillose epidermis and cortical cells filled with pigment, 
longitudinally cut fragments of vascular bundles showing spiral tracheid’s and 
vessels(29). 
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Chemical Constituents: 
Three crystalline colouring matters. 
➢ α – crocetin  
➢ β – Crocetin  
➢ δ – Crocetin  
Bitter substances 
➢ Fatty oil  - 18-13.4%  
➢ An essential oil - 1.31% 
➢ Moisture  - 9.14% 
➢ Nitrogen  - 2.22 - 2.43% 
➢ Ash   - 5-7% 
Chemical Composition: 
➢ Protein   - 12.6% 
➢ Fixed oil  - 4.7% 
➢ Volatile oil  - 0.8% 
➢ N. free extract  - 57.3% 
➢ Starch equivalent - 12.0% 
➢ Fibers   - 4.9% 
➢ Ash   - 4.0% 
 Saffron contains a mixture of yellow glycosides, crocin being a yellow red 
pigment, on hydrolysis crocin yield gentiobiose and crocetin. 
Average composition of commercial saffron: 
➢ Water    - 15.6% 
➢ Starch and Sugar  - 13.35% 
➢ Essential oil   - 0.6% 
➢ Fixed oil   - 5.63% 
➢ Total N. Free extract  - 43.64% 
➢ Essential oil   - 1.337% 
➢ Fixed oil   - 13.4% 
The ash is rich in potassium and phosphorous and contains traces of boron. 
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 Saffron contains the glycosides, crocin and picrocrocin together with Lycopene 
(Beta-carotene), grana carotene and zeaxanthin and a crystalline hydrocarbon. 
 Crocin is the chief colouring principle in saffron on hydrolysis.  It yields the 
carotenoid pigment crocetin. 
 The colourless bitter glycoside, Picrocrocin gives on hydrolysis, glucose and 
the aldehyde safranol. 
 The essential oil of saffron deposits on standing stearoptene probably a tertiary 
alcohol (30). 
Action: 
 It has a peculiar aromatic odour and a bitter, pungent taste, it is stimulant, 
Aphrodisiac and stomachic, slightly anodyne and antispasmodic, it has also 
Emmenagogue virtues, in over- doses it is narcotic poison.  It is used in small doses ¼ 
to ½ grain, ordinary dose is 1 to 3 grains. “The essential oil from Crocus sativus when 
passed through Pharmacological tests showed all the characteristic features of an 
essential oil, therefore its Aphrodisiac virtue are probably due to the slight stimulation 
of the central nervous system which is common to all essential oils”. (Chopra’s “I.D of 
me”).  
Medicinal uses: 
➢ Saffron is used principally for its coloring and flavoring properties. 
➢ It is used as sedative and Emmenagogue. It is used occasionally in 
exanthemata’s disease to subside eruptions. 
➢ It is used in fevers, Melancholia and enlargement of the liver. 
➢ It is also stimulant and stomachic. 
➢ Saffron is highly valued spice and coloring agent often cited folk remedy for 
various types of cancer (e.g.) tumors of abdomen, bladder, ear, eye, kidney, 
spleen, stomach, tonsils.  It is used as a nervine sedative and given in fevers 
melancholia and enlargement of liver. 
➢ In Europe, used as carmine, dysmen and hysteria and Aphrodisiac. 
➢ Unani medicine used as a cardio tonic and strengthens inner part of the body 
preventing premature ejaculation.  
➢ Used as Blood purifier. 
REVIEW OF LITERATURE 
 
OVULATION INDUCING ACTIVITY OF SOODHAGA MEZHUGU               27 
 
➢ The stigma of Crocus sativus was investigated for its effect on the blood 
coagulation. Fibrinolysis system and platelet aggregation. It showed remarkable 
inhibitory effect on blood coagulation. 
 
1. CLOVES ( கிராம்பு ) : 
                
            Fig.No.4. Cloves ( கிராம்பு )                          Fig.No.5. Clove oil (கிராம்பு தைேம்) 
Classification: 
   Kingdom : Plantae 
                  Class  : Eudicots 
  Subclass : Rosids 
  Order  : Myrtales 
  Family  : Myrtaceae 
  Genus  : Syzygium 
  Species : aromaticum 
Distribution: 
 A tree cultivated in many parts of the world and extent in south India. Tamil 
Nadu and Kerala. 
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Description: 
 An evergreen tree, 9-12 m high or more. Leaves ovate-oblong, acute at both 
ends, gland-dotted, fragrant, Flower-buds borne in terminal, small clusters of branches, 
greenish; pink at maturity, aromatic. Fruits fleshy, dark pink drupes. Seeds oblong, 
grooved in one side. 
 Flowers between January-June and fruits later. 
Parts used: Flower bud 
Macroscopical characters  
 Flower buds are measuring 10 to 17.5mm in length. Colour- Dark brown to 
black four-sided hypanthium readily exuding oil when pressed odour strongly aromatic 
taste pungent. Aromatic followed by slight tingling of the tongue 
Microscopical characters  
 Small number of stone cells and prismatic crystals of calcium oxalate present in 
stalk. Stamens each with an oil gland in the apex of the connective, triangularly 
ventricular pollen grains. Other walls showing a typical fibrous layer, schizolysigenous 
glands found in all parts. 
Powder 
 Dark brown; fragments of parenchyma showing large, oval, schizolysigenous 
oil cavities; spiral tracheid and a few rather thick walled, spindle shaped fibres calcium 
oxalate crystals in rosette aggregates fragments of anther walls with characteristic 
reticulated cells, pollen grains numerous (31). 
Chemical constituents:  
 Mainly β-caryophyllene eugenol and its acetate, methylsalycylate η-amyl carbinol, 
benzyl alcohol, dimethyl furfural, furfuryl alcohol, α-methyl furfural, methyl alcohol, 
methylenate, methyl furfuryl alcohol ethyl-n-hepatylketone, methyl-n-hepatylcarbinol, 
valeraldehyde, vanillin, 2,6-dimethyl-5-hydeozy-7-methoxychromone (Eugenitin), 
2,8-dimethyl-5,7-dihydroxychromone (Isoeugenol), 2-methyl-5-hydroxy-7-
methoxychromone (Eugenine), 2,4,6-trimethoxybenzoyl acetone (Eugenone), from 
flowers-bud oil of wild cloves; furfural, methyl alcohol, naphthalene (Clove stem oil); 
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benzaldehyde, carvacrol, α-humulene, meth eugenol, eugenine, eugenone, 
epoxydihydrocaryophylle, methyl-n-amyl ketone, methyl pentanone, naphthalene 
(Leaf oil) caryophylla-3(12), 6-dien-4-ol, caryophylla-3(12), 7(13)-dien-6 α-al, 
caryophyllene oxide, 2-hydroxy-4,6-dimethoxy-5-methylaceto-phenone (Clove oil) 
galactose, glucose, fructose, rhamnose, sucrose, xylose, Gallo tannic and oleanolic 
acids are isolated from the cloves. 
Medicinal Uses 
➢ Dried flower-buds: Antispasmodic, aromatic, carminative, stimulant 
➢ Beneficial in colic, dyspepsia, flatulence and various forms of gastric 
irritability, sore throat and in strengthening of gum, infusion given to allay thirst. 
➢ Paste applied externally with much benefit in coryza and headache. 
➢ Employed in Ayurvedic formulations for bronchitis, debility, dyspepsia and 
giddiness. 
➢ Clove oil is antiseptic, local anesthetic, counter irritant and rubefacient. 
➢ Externally applied in lumbago, neuralgia, rheumatic pains, sciatica and 
toothache (32).  
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3.2. DISEASE REVIEW 
3.2.1. SIDDHA ASPECT  
SOOTHAGA VAYU  
Other names:  
➢ Soodhaga kattu  
➢ Ruthuneer katti   
➢ Soodhaga katti  
➢ Soodhaga thiratchi  
➢ Soodhaga noi  
➢ Soodhaga kolaru 
 
“சித்தான கர்ப்ேத்தில் பசர்ந்திடும் இரத்தந்தான்  
வத்தாம் வுருண்டு வாயுபோல் ஓடிடும் 
வற்ற ேசிபோகும் உழன்பற இதறந்திடும் 
வற்றாக கழிச்சோம் வன்சூதக வாயுபவ” 
- திருமூேர் கருக்கிதட வயித்தியம் 600(33). 
Soodhaga vayu refers to a condition of building up of or accumulation of vayu 
and blood in the uterine cavity. This runs around the womb and result in loss of appetite, 
flatulence and dysentery. 
“பகளுபெ சூதகத்திேக்கினி வாய்வு 
மகடுத்துவிடும் ொதவிடாய் கட்டி போகும் 
ஆளுபெ கருக்குழியும் தூர்ந்து பதகம் 
அப்ேபன யுதிரெது அடிமூேத்தில் 
நீளுபெ சூதகத்தில் வாய்வு பதான்றி 
பநரான அடிவயிறு வலிப்புக் காணும் 
ோளுபெ ததேவலிக்கும் இடுப்பு தளச்சல் 
ேக்குவொய் ெருந்துண்ேத் தீருந்தாபன” 
- ஆவியளிக்கும் அமுதமுதறச் சுருக்கம் (34). 
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Soodhaga vayu may be compared to Poly cystic ovarian syndrome, which is 
characterized by vayu accumulation in the uterus may lead to amenorrhea, lower 
abdomen pain, head ache, low back ache etc.  
 Karppa vayu & Pcos   
“வ ாருமிரத்தந்ததன ெறித்துப் போதமிகவும் வலியுனண்டாங்க 
குருதிபசரா வயிறுவலிபோங் மகாள்ளுங் கர்ப்ேந்ததன யழிக்கும் 
வருடி யிடுப்புக் குதடந்துதளக்கும் ெேத்ததமிகவும் மிறுக்கிக்கி 
மேருகப் ேதனக்கும் எனப் மேரிபயார் பேசுங்கர்ப்ேவாயுவிபத” 
                    - அகத்தியர் ஆயுள்பவதம் 1200(35) 
 
According to Siddha principles, the PCOS is a kind of vayu disorder called 
karppa vayu which is characterized by frequent miscarriages, abdominal pain, low back 
ache and severe constipation.  
Nirandhara maladu & PCOS  
“நவின்றடபவ யிடுப்புவயிற் மேருத்துக் காணும் 
நேொன பெனியது வூதிக் காணும் 
குவின்றிடபவ மும்ெடிப்பு வயிற்றில் பதான்றும் 
குேவதியாந் பதவதா மேண்ோ னாலும் 
நவின்றிடபவ சன்ெத்தின் ெேபட யாகும் 
சதாகாேங் கருப்ேெது தரியா மதன்று 
புவின்றிடபவ யூகிமுனி சிகிச்சா சாரம் 
புகன்றிட்டார் போகத்து ொந்தற் காபெ” 
- யூகி தவத்திய சிந்தாெணி(36). 
 
Siddha Yugi muni in the above lines says that the symptoms of Nirandhara 
maladu are obesity, increased waist hip ratio, flabby abdomen with three folds of skin. 
He further says that females with these features may suffer from infertility. These 
symptoms can be correlated to PCOS in modern terms.   
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சூதக ந ோய் வரும்வழி: 
“தரணியில் மேண்களுக்கு மகற்ேபநாய்கள் 
நயக்கபவ வந்து மதன்னமவன்றால் தெந்தா 
நன்தெயுடன் ருதுவாகும் நளிற்றாபன 
ெயக்கபவ ொப் ோண்டம் ோல் ேழத்தினாபே 
வந்துதடா சூதகத்தின் வாயு தாபன 
தாமனன்ற கருக்குழியில் வாய்வு தங்கி 
தளர்ந்த மதாரு பசாதரயினால் ததசதான் மூடி 
ஊனன்ற பதககமெல்ோம் ெதர்த்து நல்ே 
உண்தெயுள்ள அடிவயிற்றில் வலியுண்டாச்சு 
ோமனன்ற கருக்கழிதான் விளக்க ென்றி 
ேரொன விந்துவங்பக அணுகாததயா 
ஏமனன்றால் ஆதியிபே வாய்வு மகாண்டு 
இருந்ததினால் மகற்ேெது இல்தே தாபன” 
- அகத்தியர் அமுத கதே ஞானம்(37) 
 
The above lines explain the etiology of reproductive diseases according to 
Siddha science. It says consumption of high calorie diet like starchy foods, milk, fruits 
during menstruation results in accumulation of Vayu in the uterine cavity. This leads to 
reduced blood flow to the organ resulting obesity, abdominal pain and finally failure of 
conception.    
    
“இதசந்தமதாரு மேண்ெேடு எங்குமில்தே 
.....னாபே ெேடான பசதிபகளு 
அதசந்திருக்கும் பேயாலும் பித்தத்தாலும் 
அடிவயிறு மநாந்துவரும் வாயுவாலும் 
பிதசந்தகர்ப்ேப் புழுவாலும் கிரகத்தாலும் 
பிணியாலும் பெகதவ சூரியாலும் 
துசங்மகட்டக் கேவியினால் பூமவாதுங்கித் 
துேங்காெற் பிள்தளயில்தே மசால்ேக்பகபள” 
- ேதிமனண் சித்தர்கள் ோடிய  தவத்திய சில்ேதறக் பகாதவ(38).   
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Naadi nadai:   
“ொதர் தக மிடித்தபோது வந்திடும் நாடி மூன்றும் 
பசதொயிற்று நின்று பசரபவ ேதித்து நிற்கில் 
ஓதுபெ சூதகத்தில் ஓங்கிய வாய்வு நின்று 
பேதொய் வாதத ேண்ணி பிணியிதன விதளக்குந்த் தாபன” 
- அகத்தியர் அமுத கதே ஞானம்(39). 
When the naadi is felt in women if all the 3 naadi’s are found diffused and then 
felt together then those women are subjected to menstrual troubles and those women 
has Soodhaga vaayu and has different types of physical, characteristic and mental 
changes leads to problems.   
3.2.2 MODERN ASPECT OF THE DISEASE 
History: 
Stein and Leventhal are regarded as the first investigators of polycystic ovary 
syndrome (PCOS), it was Vallisneri, an Italian medical scientist, physician and 
naturalist, who in 1721 described a married, infertile woman with shiny ovaries with 
a white surface and the size of ovaries as pigeon eggs (40). Many scientists tried to 
explain the pathophysiology of PCOS and many studies were made. It is now accepted 
that it is multifactorial, partly genetic. 
Other Names: 
➢ Polycystic Ovarian Disease 
➢ Functional Ovarian Hyperandrogenism 
➢ Ovarian Hyperthecosis 
➢ Sclerocystic Ovary Syndrome  
➢ Stein-Leventhal Syndrome (41)  
Definition: 
Polycystic ovary syndrome (PCOS) is one of the most common heterogenous 
endocrinological and metabolic disorders in premenopausal women. Heterogeneous 
by nature, PCOS is defined by a combination of signs and symptoms of androgen 
excess and ovarian dysfunction in the absence of other specific diagnoses (42). 
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PCOS includes chronic non-ovulation and hyperandrogenaemia associated 
with normal or raised oestrogen (E2), raised LH and low FSH/LH ratio. 
PCOS is a problem with hormones that affects women during their 
childbearing years (age 15 to 55) age group have PCOS (43). 
PCOS is a “syndrome”, or group of symptoms that affects the ovaries and 
uterus. Its three main features are: 
➢ Cysts in the ovaries 
➢ High levels of male hormones 
➢ Irregular or skipped periods.  
The diagnosis and treatment of PCOS are not complicated, requiring only the 
judicious application of a few well-standardized diagnostic methods and appropriate 
therapeutic approaches addressing hyperandrogenism, the consequences of ovarian 
dysfunction and the associated metabolic disorders.  
There are three recognized definition diagnose to PCOS, among The Rotterdam 
Criteria consider at least two of three criteria between clinical or biochemical 
hyperandrogenism, menstrual irregularity and polycystic ovaries characterized by 
ultrasound detection of 12 or more follicles (44). 
In 1990 the National Institutes of Health (NIH) proposed that PCOS might be 
diagnosed with hyperandrogenism and irregular menstrual cycles without knowledge 
of ovarian ultrasound pattern (45).  
Causes: 
The exact cause of PCOS is unknown. This heterogenous is characterized by 
excessive androgen production by the ovaries mainly. PCOS is a multifactorial and 
polygenic condition. However, several studies have suggested that insulin resistance 
plays an important role in the pathogenesis of the syndrome. As a consequence of 
insulin-resistance, women affected by PCOS often present abnormalities of glucose 
metabolism and lipid profile and have an increased risk of type 2 diabetes and 
cardiovascular disease over-time (46). 
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Risk factors: 
➢ Abdominal Adiposity 
➢ Insulin Resistance 
➢ Obesity 
➢ Metabolic Disorders  
➢ Cardiovascular disease 
Pathogenesis: 
Polycystic ovaries develop when the ovaries are stimulated to produce excessive 
amounts of male hormones (androgens), particularly testosterone, by either the release 
of excessive luteinizing hormone by the anterior pituitary gland, high levels of insulin 
in the blood (hyperinsulinemia) in women whose ovaries are sensitive to this stimulus 
or reduced levels of sex-hormone binding globulin (SHBG) resulting in increased free 
androgens.  
The syndrome acquired its name due to the common sign on ultrasound 
examination of multiple ovarian cysts which represent immature follicles. The follicles 
have developed from primordial follicles but the development has stopped at an early 
antral stage due to the disturbed ovarian function. The follicles may be oriented along 
the ovarian periphery appearing as a ‘string of pearls’ on ultrasound examination. 
Patients with PCOS have higher Gonadotrophin releasing hormone (GnRH), which in 
turn results in an increase in LH/FSH ratio in females with PCOS. The majority of 
patients with PCOS have insulin resistance and/or obesity.  
Their elevated insulin levels contribute to or cause the abnormalities seen in the 
hypothalamic-pituitary-ovarian axis that lead to PCOS. Hyperinsulinemia increases 
GnRH pulse frequency, LH over FSH dominance, increased ovarian androgen 
production, decreased follicular maturation and decreased SHBG binding. All these 
factors contribute to the development of PCOS.  
PCOS is characterized by a complex positive feedback of insulin resistance and 
hyperandrogenism. In most cases, it cannot be determined which of those two should 
be regarded to be the causative agent. Experimental treatment with either anti-
androgens or insulin sensitizing agents improves both hyper-androgenism and insulin 
resistance. Adipose tissue possesses aromatase, an enzyme that converts 
androstenedione to estrone and testosterone to estradiol.  
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The excess of adipose tissue in obese patients causes them to have both excess 
androgens (which are responsible for hirsutism and virilization) and estrogens (which 
inhibit FSH via negative feedback). PCOS may be associated with chronic 
inflammation of the ovary which may induce conformational, endocrinal and metabolic 
changes which may predispose to PCOS. Several studies correlate the inflammatory 
mediators and oxidative stress with anovulation and other PCOS symptoms.  
It was previously suggested that the excessive androgen production in PCOS 
could be caused by a decreased serum level of insulin-like growth factor binding 
protein-1 (IGFBP-1), in turn increasing the level of free IGF-1 which stimulates ovarian 
androgen production, but recent data concludes this mechanism to be unlikely. PCOS 
has also been associated with a specific fragile X mental retardation 1 (FMR1) sub-
genotype. Many studies suggested that women who have heterozygous-normal/low 
FMR1 have polycystic-like symptoms of excessive follicle-activity and hyperactive 
ovarian function (47). 
Relationship between PCOS and Insulin resistance: 
➢ Insulin-resistance and hyperinsulinemia are tightly related to pathogenesis of 
PCOS which may be exacerbated by coexistence of obesity. Nevertheless, many 
studies showed that insulin resistance affected also normal weight women with 
PCOS. Besides, in lean patients with PCOS the visceral adiposity. 
➢ PCOS also had impaired 𝛽 cell function and the grade of dysfunction seems to 
be related to family history of type II diabetes. Furthermore, hyper insulinemic 
insulin resistance stimulates the ovarian androgen production and increases the 
likelihood to develop type 2diabetes, metabolic syndrome, and cardiovascular 
disease. 
Relationship between PCOS and obesity 
Obesity and insulin-resistance were significant risk factors to develop, the 
prevalence of type 2 diabetes. Dyslipidaemia is one of most frequent features in patients 
with PCOS. Hyperinsulinemia and insulin-resistance are related to abnormality of lipid 
profile, particularly to decreased levels of high-density lipoprotein cholesterol (HDL-
C) levels and increased levels of triglycerides and of small dense low-density 
lipoprotein cholesterol (LDL-C). 
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Insulin-resistance causes a rise in free fatty acid (FFA) plasma levels due to 
increased synthesis from liver and increased mobilization from adipose tissue. The 
excess of FFA leads to insulin-resistance by inactivation of key enzymes such as 
pyruvate dehydrogenase (PDH) or by decreasing glucose transport activity, which may 
be a consequence of altered insulin signalling through decreased insulin receptor 
substrate-1 (IRS-1) associated PI3 kinase activity.  
Clinical Manifestations:  
Dermatological clinical manifestations of hyperandrogenism include: 
Hirsutism: 
Hirsutism defined as an excessive growth of terminal hair in androgen 
dependent areas of women. (Is one of the most widely used clinical criteria for the 
diagnosis of androgen excess and is observed in 50% - 80% of patients with 
hyperandrogenism) 
Acne: 
Acne is a disorder of the pilo sebaceous unit, with lesions on the face, neck, 
back and chest area. The importance of androgens in the acne pathogenesis is well-
known and authenticated. 
Androgenetic Alopecia: 
The Androgenetic alopecia in women is characterized by hair loss in the central 
region of the scalp, with important psychosocial repercussions. Most patients with 
Androgenetic alopecia have the normal endocrine function. 
Acanthosis nigricans: 
Acanthosis nigricans characterized by the presence of a brown and velvety plate 
with accentuation in the furrows of skin. The dermatopathology is most commonly 
observed in the neck and intertriginous areas such as armpits, groin and infra mammary 
region and it is reported in 5% of patients PCOS seborrhoea, in severe cases, signs of 
virilization will present (48). 
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The symptoms of PCOS include:  
➢ Irregular periods or absence of menstruation 
➢ An increase in facial or body hair (hirsutism)  
➢ Loss of hair on head 
➢ Being overweight, experiencing a rapid increase in weight or having difficulty   
losing weight 
➢ Oily skin, acne 
➢ Difficulty becoming pregnant (reduced fertility). 
Depression and psychological problems can also result from PCOS. The symptoms 
vary from woman to woman. Some women have very few mild symptoms, while others 
are affected more severely by a wider range of symptoms (49). 
Diagnostic Criteria for PCOS: 
NIH criteria:  
In 1990, a workshop sponsored by the NIH suggested that a patient has PCOS 
if she has oligoovulation, signs of androgen excess (clinical or biochemical) and other 
entities are excluded that would cause polycystic ovaries. 
Rotterdam criteria:  
In 2003, a consensus workshop held in Rotterdam indicated PCOS to be present 
if any 2 out of 3 criteria including oligo ovulation and/or anovulation, excess androgen 
activity and polycystic ovaries (By gynaecologic ultrasound). The Rotterdam definition 
is wider, including many more patients, most notably patients without androgen excess. 
Critics say that findings obtained from the study of patients with androgen excess 
cannot necessarily be extrapolated to patients without androgen excess. 
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Table.No.1. Diagnostic Criteria for PCOS 
S.no Symptoms NIH (1990) 
necessary 
criteria. 
Rotterdam 
criteria (2003) 
necessary at 
least 2 criteria 
Androgen 
Excess PCOS 
Society (2009) 
necessary at 
least criteria 
1 Clinical hyperandrogenism or 
biochemical 
hyperandrogenism 
Obligatory 
presence 
Possible 
presence 
Obligatory 
presence 
2 Oligo / an ovulation may 
manifest with frequent or 
infrequent bleeding. 
Obligatory 
presence 
Possible 
presence 
Possible 
presence 
3 Ultrasound Polycystic 
Ovarian features presence of 
12 or more follicles 2-9 mm 
in diameter. 
- Possible 
presence 
Possible 
presence 
 
Androgen excess PCOS Society criteria:  
In 2006, the Androgen Excess PCOS Society suggested a tightening of the 
diagnostic criteria to all of the following including excess androgen activity, 
oligoovulation/ anovulation, polycystic ovaries and other entities are excluded that 
would cause excess androgen activity (50). 
Differential Diagnosis: 
➢ Hypothyroidism 
➢ Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)  
➢ Cushing’s Syndrome 
➢ Hyper-Prolactinemia 
➢ Androgen Secreting Neoplasms  
➢ Pituitary or Adrenal Disorders (51)  
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Diagnosis: 
➢ CT, USG 
Laboratory Tests:  
➢ Serum levels of androgens, including androstenedione and testosterone may be 
elevated. Dehydroepiandrosterone sulfate (DHEA-S) levels above 700-800 
mcg/dl are highly suggestive of adrenal dysfunction. The free testosterone level 
is thought to be the best measure, with about 60% of PCOS patients 
demonstrating high levels. 
➢ The ratio of LH (Luteinizing hormone) to FSH (Follicle stimulating hormone) 
is greater than 1:1 (sometimes more than 3:1), as tested on day 3 of the menstrual 
cycle.  
➢ Fasting biochemical screening and lipid profile.  
➢ Two hours oral glucose tolerance test (GTT) in patients with risk factors 
(Obesity, family history, history of gestational diabetes) may indicate impaired 
glucose tolerance (insulin resistance) in patients with PCOS]. 
➢ Fasting insulin level or GTT with insulin levels (also called IGTT): Elevated 
insulin levels have been helpful to predict response to medication and may 
indicate patients who will need higher doses of metformin or the use of a second 
medication to lower insulin levels. A hypoglycemic response in which the two-
hour insulin level is higher and the blood sugar lower than fasting is consistent 
with insulin resistance.  
May also include, 
➢ Serum prolactin 
➢ Serum androstenedione 
➢ Pelvic ultrasound 
➢ Basal body temperature monitoring 
➢ Luteal phase progesterone measurement (52)  
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Complications: 
Short term complications 
➢ Menstrual irregularities 
➢ Hyperandrogenism 
➢ Infertility 
➢ Obesity 
➢ Pregnancy complication 
➢ Obstructive sleep apnea 
➢ Insulin resistance and hyperinsulinemia 
Long term complications: 
➢ Endometrial carcinoma 
➢ Metabolic syndrome 
➢ Cardio vascular disease 
➢ T2DM / impaired glucose tolerance 
➢ Nonalcoholic steatohepatitis 
➢ Psychological disorders (53) 
Treatment: 
Classification of ovulation inducing drugs:  
➢ Synthetic GnRH  
➢ Human menopausal and chronic gonadotropins  
➢ Bromocriptine  
➢ Antiestrogenic compound 
Other classification based on treatment: 
➢ First-line treatment       - Clomiphene citrate. 
➢ Second-line treatments include  - Gonadotropins. 
          Laparoscopic ovarian surgery. 
➢ Third-line treatment        - In Vitro fertilization. 
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1. GnRH  
Effects: 
➢ Assessment of the function of the pituitary gonadotropins.  
➢ Induction of ovulation.  
➢ Treatment of males and females with idiopathic, hypothalamic, 
hypogonadotropic hypogonadism (Kallmann syndrome).  
Adverse reactions: 
 Hot flushes, wearing, vaginal dryness, Headache, occasionally diminished 
libido and depression, prolonged treatment causes osteoporosis.  
2. Human menopausal urinary Gonadotropin (hMG, Menotropins, Pregonal):  
Effects:  
 Induce ovulation in women with anovulation due to pituitary-hypothalamic 
disorders but with normal ovaries and poly cystic ovaries.  
Adverse reactions:  
 Hyperstimulation syndrome due to this the ovaries become very large and 
friable, abdominal pain, nausea, ascites and Shock.  
3. Bromocriptine (Bromocriptine, Parlodel, Proctinal)  
Effects: 
 It inhibits hyper prolactinemia and stops galactorrhoea. It lowers the serum 
prolactin levels and restores potency in males.  
4. Antiestrogenic compound:  
➢ Clomiphene citrate   
Effects - Infertility treatment (ovulation induction) 
Contraindications:  
Allergy to Clomiphene – Pregnancy, hepatic disease, primary hypopituitarism, 
disturbed thyroid or adrenal function, uterine bleeding of unknown aetiology, hormone-
dependent tumours. 
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Adverse effect: 
  Headache, vertigo, tiredness, disturbed vision, nausea, vomiting, vasomotor 
symptoms, facial flush, mastalgia, abdominal pain, paramania. 
➢ Metformin  
Effects - Restores regular bleeding and ovulation, reduces insulin resistance, improves 
arterial tension values, improves lipid profile, increases sex hormone binding globulin 
(SHBG) level may help reduce body weight. 
Contraindications: 
Hypersensitivity, renal insufficiency, acute or chronic diseases that may cause 
tissue hypoxia such as cardiac or respiratory insufficiency, lactation and hepatic 
damage. 
Adverse effect: 
Gastrointestinal disorders, lactic acidosis, dyspepsia, diarrhoea, nausea, flatulence. 
➢ Eflornithine  
Effects - Controls facial hirsutism   
Contraindication: 
Hypersensitivity to eflornithine or any adjuvant 
Adverse effect: 
  Acne, chronic folliculitis barbae, alopecia, skin burning sensation, xeroderma, 
itching, erythema and skin formication 
➢ Spironolactone 
Effects: Inhibits androgens  
Contraindications:  
Hyperkalaemia, touch-sensitive nipples, mastalgia, menstrual disorders, 
hirsutism, agranulocytosis, headaches, sleepiness and ataxia. 
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Adverse effect: 
Hypersensitivity, hyponatremia, hyperkalaemia, primary adrenal insufficiency, 
severe renal and hepatic failure and acute renal failure (54). 
Laparoscopic surgery:  
In women for whom CC or gonadotropin treatment is unsuccessful, another 
commonly used approach is ovarian surgery. Although there are several different 
techniques, they all involve acute ovarian tissue damage. Various types of ovarian 
surgery have been employed (wedge resection, electro cautery, laser vaporization, 
multiple ovarian biopsies and others). All of these procedures result in a positively 
altered endocrine proﬁle after surgery.  
Advantages of Surgery: 
Direct visualization: The surgeon can directly see the structures on which she is 
operating. 
Observe nearby areas: In addition to treating the ovaries, the physician can visualize 
nearby structures and assess their health and condition, noting any other areas that may 
be of concern. 
Disadvantages: Surgical Risks and Challenges: 
Anesthesia complications: Recent studies note concerns about neurotoxic effects on 
the brain and other areas of the body for patients who undergo one or more sessions of 
general anesthesia. 
Inadvertent enterotomy: When a patient has significant adhesions, it can be difficult 
for the doctor to see the structures beneath them. Thus, a surgeon can unintentionally 
cut into a nearby healthy organ or other structure – called an inadvertent enterotomy 
(IE). An IE can cause serious problems or death (55).  
IVF (In Vitro Fertilization) (56) 
The first ‘IVF baby’, Louise Brown, was born using natural IVF in 1978. Since 
then, the technology has advanced, and techniques refined in order to create safer and 
successful treatment.  
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Advantages of IVF: 
IVF helps many patients who would be otherwise unable to conceive: The ultimate 
advantage of IVF is achieving a successful pregnancy and a healthy baby.  
PCOS: 
Polycystic ovary syndrome is common condition in which there is a hormone 
imbalance leading to irregular menstrual cycles. IVF has proved very successful in 
patients with PCOS, who will not conceive with ovulation induction. 
There was a disadvantage are present in the IVF. 
Diet Advice: 
PCOS too needs a relatively strict lifestyle approach with regular exercise, 
movement and a high protein diet to help manage insulin levels and support weight 
loss. 
Food to add: 
➢ High-fiber vegetables, cruciferous vegetables, such as broccoli, cauliflower and 
Brussels sprouts 
➢ Lean protein, such as fish  
➢ Anti-inflammatory foods and spices, such as turmeric and tomatoes 
➢ Greens, including red leaf lettuce and arugula and red peppers 
➢ Beans and lentils 
➢ Almonds 
➢ Berries 
➢ Sweet potatoes 
➢ Winter squash 
Food to avoid: 
➢ Foods high in refined carbohydrates, such as rice, white bread and muffins 
➢ Sugary snacks and drinks 
➢ Inflammatory foods, such as processed a red meat 
➢ Breakfast pastries 
➢ Sugary desserts 
➢ White potatoes 
➢ Anything made with white flour (57) 
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Siddha drugs for PCOS:   
Chooranam:   
➢ Thratchathy chooranam -1 to 2 gm twice a day with honey (5 ml)   
➢ Inji chooranam - 1 to 2gm twice a day with water (50 ml)  
➢ Seenthil chooranam -1 to 2 gm twice a day with hot water (5 ml)   
➢ Karisalai chooranam-1 to 2 gm thrice a day with honey (5 ml)  
➢ Asoka pattai chooranam -1 to 2 gm thrice a day with hot water (50 ml) 
➢ Attathi chooranam  - 1 to 2 gm twice a day with hot water (50 ml) 
➢ Thirikadugu chooranam -1 to 2 gm twice a day with honey (50ml) 
➢ Meni Lavana Chooranam - 1to 2 gm twice a day with honey(50ml) 
Nei:  
➢ Bhrami nei-10 to 15 ml at early morning  
➢ Senkottai nei-15 ml twice a day  
➢ Venpoosani nei-15 ml twice a day  
➢ Thanneervittan nei- 10 ml twice a day  
Manapagu:  
➢ Thurunchi manapagu-10 to 20 ml twice a day with Luke warm water(50ml)  
➢ Madhulai manapagu-10 to 15 ml twice a day with hot water  
Ilagam:  
➢ Vilvathy ilagam-5 to 10gm twice a day  
➢ Nellikai ilagam-5 to 10gm twice a day  
➢ Karisalai ilagam-5 to 10gm twice a day  
➢ Kumarai ilagam-5 to 10gm twice a day  
➢ Thaneervittan ilagam-5 to 10gm twice a day  
Mezhugu:  
➢ Gunma kudori mezhugu-500 to 1000 mg twice a day  
➢ Rasagandhi mezhugu-300 mg twice a day with 5gm palm jaggery  
➢ Vaan mezhugu-50 to 100 mg twice a day with 5gm palm jaggery  
➢ Rasa mezhugu- 100 to 200 mg twice a day with 5gm palm jaggery  
➢ Nandhi mezhugu- 100 to 200 mg twice a day with 5gm palm jaggery  
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Rasayanam:  
➢ Gandhaga rasayanam-1.3 to 2gm twice a day   
Maathirai: 
➢ Maha vasantha kusumaahara maathirai (100 mg)  - 1 to 2 mg twice a day 
with 10 ml leaf juice of karisalai  
➢ Sambirani poo guligai (130 mg)   - 1tab with sugar 
Theeneer:  
➢ Lavana thiravagam - 1 to 2 drops twice a day with water 
➢ Sanga thiravagam - 1 to 2 drops twice a day with water 
Parpam:  
➢ Kungiliya parpam-100 to 300 mg twice a day with ghee (5 ml)  
➢ Muthu parpam-30 to 60 mg twice a day with ghee (5 ml)  
➢ Muthuchippi parpam-200 to 400 mg twice a day with ghee (5 ml)  
➢ Palagarai parpam-65-130 mg twice a day with milk (50 ml)  
➢ Sangu parpam-30 to 60 mg twice a day with ghee (5 ml) 
➢ Panja lavana parpam - 30 to 60 mg twice a day with ghee (5 ml) 
Chendooram:  
➢ Vediannabedi chendooram-100 mg twice a day with hot water (50 ml)  
➢ Kalluppu chendooram-488 mg twice a day with honey (5 ml)  
➢ Pattu karuppu- 65 to 130 mg twice a day with honey (5 ml)  
➢ Kariyuppu chendooram- 65 to 130 mg twice a day with honey (5 ml) 
➢ Aarumuga chendooram-65 to 130 mg twice a day with honey (5 ml )   
➢ Ayakandha chendooram-65 to 130 mg twice a day with honey (5 ml ) 
➢ Aya chendooram -65 to 130 mg twice a day with honey (5 ml )  
➢ Thalaga chendooram-30 to 65 mg twice a day with 50 ml milk  
Thylam:  
➢ Kalingathy thylam-280 gm with 50 ml cold rice water from the first day of 
mensturation  
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Kuzhambu:  
➢ Kumatty kuzhambu-130 mg with 5gm palm jaggery for 3 days from the first day 
of menstruation (58). 
Yoga for PCOS: 
➢ Pranayamam 
➢ Surya Namaskaram (Sun Salutation), Bhujangasanam (Cobra Pose), 
Salabhasanam (Locust Pose), Dhanurasanam (Bow Pose), Trikonasana 
(Triangle Pose), Parsva -konasanam (Twisted Angle Pose), Sarvangasanam 
(Shoulder Stand), (Paschimottanasanam), fixed angle Pose, Savasanam(59). 
3.3. PHARMACOLOGICAL REVIEW (60) 
Animal models for the study of PCOS:  
To identify the complex nature of this disease, suitable animal models are 
needed. Researchers during the past three decades have identiﬁed different animal 
models that mimic many of the features of PCOS in women. These models have 
afforded valuable information into complex nature of PCOS. Currently, although a 
genetic component to PCOS has been identiﬁed, a speciﬁc “PCOS gene” has not, and 
therefore a speciﬁcally targeted gene deletion for PCOS as an animal model is not 
available. Therefore, the majority of PCOS models that are available to date rely upon 
external chemical treatments with steroids, steroid precursors or steroid receptor 
antagonist to achieve the pathology. Many of these models do not produce consistent 
results or cease to produce PCOS like symptoms once the treatment stops. Recently, 
Hill et al. noted that their model for cardiovascular disease, the hypothalamic pro-
opiomelanocortin (POMC) speciﬁc leptin-insulin double receptor knockout mouse 
exhibited some similar features to PCOS. Recently developed theca speciﬁc Esr1 
speciﬁc knockout mouse model reproduces the clinical pathologic features of PCOS in 
100% of animals. 
Animal preparation: 
Virgin, cyclic, adult female Wistar Albino rats (160–200 g) were employed for 
the study. Animals were acquired from Animal house. During the study all animals 
were caged in standard polypropylene cages and maintained in controlled environment 
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of (22 ± 3) C temperature, (55 ± 5) % humidity and a 12 h light/ dark cycle. They were 
fed with standard diet and water provided ad libitum. The study was duly approved by 
Institution Animal Ethics Committee (IAEC) for the use of animals and care of the 
animals was carried out as per the guidelines of committee for the purpose of control 
and supervision of experiments on animals (CPCSEA).  
Letrozole induced 
Letrozole is an oral non-steroidal aromatase inhibitor. Inhibition of aromatase 
prevents the conversion of androgens to estrogens and therefore this model has similar 
features to the prepubertal androgen treatment. Immature rats (approximately 21 days 
old) are treated for 7-35 days with 400 μg/day letrozole. Similarly, to pre-pubertal 
androgen, this model is also reliant on artiﬁcial hyperandrogenaemia and does not help 
identify abnormalities upstream of hyperandrogenaemia. 
Prenatal androgen 
Prenatal androgen (PNA) treatment in sheep and monkeys’ results in multiple 
metabolic and reproductive abnormalities. In monkeys, daily subcutaneous injections 
of 15 mg of testosterone propionate for 40-80 days gestation are needed to induce the 
syndrome. In ewes, an injection of 100 mg of testosterone propionate twice a week for 
60 days between days 30 and 90 of the 147-day pregnancy result in the ovarian 
abnormalities. In both models, the abnormalities mirror the symptoms found in women 
with PCOS. These models produce a long-lasting effect in the female offspring 
mimicking many similar features of PCOS in humans. However, ewes and monkeys 
incur a large ﬁnancial commitment for a long gestational period. However, it is noted 
that although PA monkeys exhibit hyperandrogenaemia, the increases are not as 
extreme as in PCOS women 0.3-0.4 ng/mL (~50-100% elevation above normal) ; PCOS 
women, 0.5-0.7 ng/mL (~70-200% elevation above normal) and that although 
anovulation observed in PNA monkeys, its prevalence is also signiﬁcantly less than that 
of PCOS women (PA monkeys: ~40%; PCOS women ~90%). 
Pre-pubertal androgen  
This model exploits the association of elevated androgen levels during puberty 
and PCOS. Immature rats (approximately 21 days old) are treated for 7-35 days with 
~100 μg/day testosterone propionate or dihydrotestosterone. Similar to the PNA animal 
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models, prepubertal androgen (PPA) animal models of PCOS utilize a unique window 
where administration of exogenous androgens results in permanent damage to the 
ovarian tissue and recapitulated the hallmark symptoms of PCOS in an animal model. 
PPA model shows many similar features to PCOS in women with the exception of the 
hallmark increase in basal LH levels. This model is reliant on artiﬁcial 
hyperandrogenaemia and therefore does not help identify abnormalities upstream of 
hyperandrogenaemia. 
Dehydroepiandrosterone (DHEA) induced  
Immature rats or mice (approximately 21-22 days old) are treated with daily 
DHEA injections (rats; 6 mg/100 g body weight, mice 6 mg/kg body weight) for 15-20 
days. This dose of DHEA is sufﬁcient to induce a hyper androgenized state similar to 
that in PCOS women. This model is also reliant on artiﬁcial hyperandrogenaemia and 
does not help identify abnormalities upstream of hyperandrogenaemia. 
RU486 induced  
Mature cycling female rats are treated daily with RU486 (20 mg/ kg body 
weight) for more than 8 days starting on the day of estrus. These animals exhibit 
increased basal LH, Polycystic ovaries, ovulation blockade and metabolic defects. 
However, this model is reversible and symptoms decrease upon cessation of the 
antiprogestin treatment.  
Estradiol induced  
The immune system is now a well-recognized component of reproductive 
biology. Immune cells are involved in all aspects of normal reproductive function 
including ovulation, corpus luteal formation, uterine receptiveness and maintenance of 
pregnancy. The recently developed PCOS model developed by Chapman and 
colleagues now provides evidence that aberrant immune function may play a role in the 
pathogenesis of PCOS and that PCOS may result from as autoimmune disease. This 
model exploits a 2-3-day window of neonatal period (5-7 days of age) when estradiol 
administration (20 μg/day) disrupts thymic maturation. As a consequence of this, 
increased vascular permeability in the thymus allows autoreactive T-cells to escape into 
the circulation. The ultimate effect of these “escapees” is a damage to tissues 
throughout the body including the ovaries. This model offers an abrupt change in the 
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direction of PCOS research. The major deﬁciencies in this model are a lack of 
hyperandrogenaemia and the fact that the loss of regulatory T-cell function would not 
only impact the ovary, but multiple other tissues resulting in pathologies not associated 
with PCOS. It will be interesting to follow the progress of this novel concept of 
autoimmune responses resulting in PCOS in women and if, PCOS women have 
deﬁciencies in regulatory T-cells.  
Hypothalamic pro-opiomelanocortin (POMC) neuron specific leptin and insulin 
receptor KO 
Hill and her colleagues were interested in insulin resistance and the 
development of type II diabetes when they developed their Pomc-Cre, Leproﬂox/ﬂox 
IR ﬂox/ﬂox mice, effectively removing both leptin and insulin receptors speciﬁcally 
from the POMC. However, together with the anticipated glucose intolerance and insulin 
deﬁciency these mice suffer from hyperandrogenaemia and polycystic ovaries. These 
two pathological conditions secure its eligibility as a model for the study of human 
PCOS. 
3.4. PHARMACEUTICAL REVIEW 
Purification processes in Siddha system (suddhiseithal) 
The process of detoxification or purification of the drug is called ‘suddhiseithal’ 
in Siddha medical terminology. 
Nature has created innumerable plant, herbs, metals, poisonous substances, 
minerals, salts and other organic substances. The Siddha had selected such of those 
things which can render relief to innumerable ailments of mankind suffered. Any matter 
in nature has to be utilized for medicine purposes the properties which may cause bad 
effects should be neutralized or eliminated. That’s why every raw drug used in Siddha 
medicine is purified before preparing it as a medicine. 
Purification 
The exact part of the herb which has been prescribed should alone be taken for 
medicine. There should not be other impurities like mud, sand or any such thing. If it is 
green leaf, dried or decomposed leaves or insects should be eliminated. Care should be 
taken in identifying the herbs properly. 
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As a general rule, when anything is subjected to be processed by using heat, 
soaking either alone or with some other substance, some chemical reaction may take 
place.  In these process impurities, toxins would be eliminated and the substances 
become purified. Hence some of the poisonous herbs which are purified by using heat. 
Importance of purification 
The drugs when subjected to heat like roasting or soaked in liquids undergo 
some chemical reactions. Such as oxidation of toxic substances to non-toxic substances, 
elimination of certain poisonous chemicals to non- poisonous substances. In these ways 
not only the toxicity, impurities or removed but also enhance the potency of the drugs.  
Mezhugu (Waxy in nature) (61): 
Definition: 
The drug that has to be made, the ingredients of it must be purified, by grinding 
or fusing attain mezhugu consistency.   
This is of two types: 
1. Araippu Mezhugu 
2. Surukku Mezhugu 
1. Araippu Mezhugu (obtained by grinding): 
Mercurial compounds are ground individually or with other raw drugs adding juices 
or honey into a semisolid form. 
2. Surukku Mezhugu: 
Obtained by heating the mercurial compounds or paadaanas by adding oily 
substances or some juices drop by drop. After it is melting and attains semisolid form 
it should be placed in a mortar and tribute and then stored. 
Storage: 
 Store it in a pure dry glass container. 
Termination period: 
 Its termination period is 5 years. 
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What is Mezhugu? 
Mezhugu is one of the 32 types of internal medicines described in Siddha system 
with a waxy consistency. Mostly it is a herbo-mineral preparation, consists of Mercury 
and mercurial salts, Paadanam (Poisonous), Kaarasaaram (Salts) and Ubarasam 
(Animal products) and processed with herbal juices. Most of the drugs in this type are 
made by the grinding process only. So, Siddhars like alchemy scientists has chosen the 
ingredients very carefully in the basis of ‘Sathru’ (Antagonist), ‘Mithru’ (Agonist) to 
nullify the toxicity and to potentiate the active principles of the drug respectively. These 
preparations are not chewable and given with the vehicle ‘Palm jaggery’. Which is a 
good anti-dote for mercurial poisoning. Also, the drug is given as embedded in the 
vehicle to reach the gastric area without making contact in buccal cavity. Because, the 
buccal mucosa is highly sensitive to the drug reactions. 
In another school of thought, Mezhugu is a one of the by product in the process 
of alchemy to attain the Gold as a goal. Almost all the Siddhar’s were explaining about 
this type, So, the importance of this kind of drug is clearly exposed.  
Table No.2. Few Other Mezhugu Names: 
S.No Drug name Book Name Page No 
1.  இடிைல்ைோதி புலிப்போணி லைத்தியம் 500 130-131 
2.  இ  கந்திசமழுகு புலிப்போணி லைத்தியம் 500 132-134 
3.  கந்திசமழுகு சித்  லைத்தியத் தி ட்டு 134 
4.  நந்திசமழுகு சித்  லைத்தியத் தி ட்டு 135-139 
5.  குன்ம குர ோரி சித்  லைத்தியத் தி ட்டு 134-135 
6.  நைஉப்பு சமழுகு சித்  லைத்தியத் தி ட்டு 139-140 
7.  பஞ் சூ  சமழுகு யூகி கரி ல் – 151 141-142 
8.  மகோவீ  சமழுகு சித்  லைத்தியத் தி ட்டு 142-143 
9.  மைக்கு ோ  சமழுகு சித்  லைத்தியத் தி ட்டு 143 
   10. இந்துைர்ண சமழுகு யூகி கரி ல் – 151 143-144 
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Table No.3. Analytical Specification of Avaleha / Leham / Ilagam (Confections / 
Semi solid)  
S.NO TESTS 
1. Description 
 Colour 
 Odour 
 Taste 
2. Loss on drying at 1050C 
3. Total – ash 
4. Acid - insoluble ash 
5. Ph 
6. Total solid 
7. Fat content 
8. Reducing sugar 
9. Total sugar 
10. Identification, TLC/HPTLC 
11. Test for heavy metals 
Lead 
Cadmium 
Mercury 
Arsenic 
12. Microbial contamination 
Total bacterial count 
Total fungal count 
13. Test for specific pathogen 
E. coli 
Salmonella spp. 
S. aureus 
Pseudomonas aeruginosa 
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14. Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
15. Test for Aflatoxins (B1, B2, G1, G2) 
 
3.5. LATERAL RESEARCH OF THE DRUG 
1. Borax: 
Antidote activity 
Evaluation of processed borax as antidote for aconite poisoning 
Results 
Protection index indicates that treated borax gave protection to 50% rats 
exposed to the lethal dose of toxicant in acute protection Study. The ventricular 
premature beat and ventricular tachyarrhythmia caused by the toxicant were reversed 
by the test drug indicate reversal of toxicant induced cardio-toxicity. The acetylcholine 
induced contractions in leech muscle were inhibited by toxicant and it was reversed by 
test drug treatment. 
Conclusion 
The processed borax solution is found as an effective protective agent to acute 
and sub-acute aconite poisoning, and aconite induced cardiac and neuro-muscular 
toxicity. Processed borax at therapeutic dose (22.5 mg/kg) has shown better antidotal 
activity profile than five times more than therapeutic dose (112.5 mg/kg) (62). 
2. Commiphora myrrha: 
Antimicrobial activity of Commiphora myrrha 
The activity of commiphora myrrh against microorganisms recovered from 
wounds  
Extracted, purified, and characterized 8 sesquiterpene fractions from C. molmol 
were a mixture of furanodiene-6-one and methoxyfuranoguaia-9-ene-8-one, which 
showed antibacterial and antifungal activity against standard pathogenic strains of 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida 
albicans, with minimum inhibitory concentrations ranging from 0.18 to 2.8 mg/ml. 
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These compounds also had local anaesthetic activity, blocking the inward sodium 
current of excitable mammalian membranes. (Dolara et al, 2000).  
The antifungal activity of Myrrha (Commiphora molmol) essential oil was 
tested against three s fungi, Aspergillus flavus, Aspergillus Niger and Penicillium 
citrinum, Results showed inhibitory effect of the oil against tested fungi with the 
increasing concentrations. Minimum inhibitory concentration (MIC) using agar 
dilution method was 4% (v/v) for A. Niger and A. flavus and above 4% (v/v) for P. 
citrinum (Batool, 2007).  
Conclusions 
Two hundred clinical isolates were obtained from wounds swab after 
bacteriological procedure, antimicrobial test of Commiphora myrrh were subjected by 
tube dilution method technique against Gram Negative and Gram-Positive organisms. 
This study concluded that: 
A. The most common pathogen isolated positive cocci from wounds was 
Staphylococcus aureus. 
B. Commiphora myrrh is suitable antimicrobial agent against Staphylococcus 
aureus. 
C. Medicinal plants remain as a potential source of antimicrobial agents (63). 
3. Crocus sativus: 
Antidiabetic potential of saffron and its active constituents  
The prevalence of diabetes mellitus is growing rapidly worldwide. This 
metabolic disorder affects many physiological pathways and is a key underlying cause 
of a multitude of debilitating complications. There is, therefore, a critical need for 
effective diabetes management. Although many synthetic therapeutic glucose‐lowering 
agents have been developed to control glucose homeostasis, they may have 
unfavourable side effects or limited efficacy. Herbal‐based hypoglycaemic agents 
present an adjunct treatment option to mitigate insulin resistance, improve glycaemic 
control and reduce the required dose of standard antidiabetic medications. Saffron 
(Crocus sativus L.), whilst widely used as a food additive, is a natural product with 
insulin‐sensitizing and hypoglycaemic effects. Saffron contains several bioactive β 
carotenes, which exert their pharmacological effects in various tissues without any 
obvious side effects. In this study, we discuss how saffron and its major components 
exert their hypoglycaemic effects by induction of insulin sensitivity, improving insulin 
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signalling and preventing β‐cell failure, all mechanisms combining to achieve better 
glycaemic control (64). 
Evaluation of Crocus sativus L. Stigma Phenolic and Flavonoid Compounds and 
Its Antioxidant Activity 
Antioxidant activity: 
The antioxidant activity of saffron could be attributed to two bioactive 
compounds, crocin and safranal, and a DPPH radical scavenging test on crocin and 
safranal exhibited antioxidant activities of 65% and 34%, respectively, at 500 ppm. In 
this study, the antioxidant activity of the methanolic extract at 300 μg/mL was 68.23%. 
Conclusion: 
Saffron stigmas were found to possess antioxidant activity, hence, saffron is a 
promising natural product in this respect. Different solvents affected the total phenolic 
and flavonoid contents of the extracts and led to the observation of different 
antioxidative efficacy. The gallic acid and pyrogallol as bioactive compounds present 
in saffron stigma contributed in its antioxidant activity. It is suggested that saffron 
stigma besides being colorant could play a role as antioxidant source, which might 
enhance the quality of the products in functional foods, beverages, drinks, 
pharmaceutical and cosmeceutical industries (65). 
Effects of saffron (Crocus sativus l. Iridaceae) on blood level of follicle-stimulating 
hormone, and number and dynamics of body weight of offspring in female rats. 
This paper reviews the effects of saffron Crocus sativus on blood level of 
follicle-stimulating hormone (FSH), and number and dynamics of body weight of 
offspring in female rats. The findings indicated that the per os administration of 
alcoholic extract of saffron was able to decrease the FSH levels in blood of the 12-
month-old rats as compared to that in the control group, involving the animals of the 
same age which have not received the saffron extract, and was close to the FSH levels 
reported for the 6-month rats. There was also an increase in number and body weight 
of pups from rats receiving the saffron extract prior to pairing with the intact males (66).  
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4. Syzygium aromaticum: 
Anti -cancer activity:  
Eugenol treated HL-60 cells displayed features of apoptosis including DNA 
fragmentation and formation of DNA ladders in agarose gel electrophoresis. Eugenol 
transduced the apoptotic signal via ROS generation, there by including MTP, reducing 
anti-apoptotic protein bcl-2 levels, inducing cytochromes c release to the cytosol, and 
subsequent apoptotic cell death (67). 
Antimicrobial and antioxidant activity of unencapsulated clove (Syzygium 
aromaticum, L.) essential oil 
Clove (Syzygium aromaticum, L.) essential oil is known for its antimicrobial 
activity against several pathogenic bacteria. Encapsulation of clove oil was proposed as 
a mean to disguise its strong odour that limits its uses in food industry. Thus, the aim 
of this study was extraction, encapsulation and assessment of the antimicrobial and 
antioxidant potential of clove essential oil. The essential oil showed high DPPH 
scavenging capacity and low hydroxyl radical inhibition. Clove essential oil showed in 
vitro inhibitory and bactericidal effect against S. aureus, E. coli, L. monocytogenes and 
S. aureus was superior to nitrite. The essential oil particles encapsulated with sodium 
alginate and emulsifiers, showed high encapsulation efficiency, low antioxidant activity 
and strong antimicrobial inhibition. Similar bacterial growth was observed in meat-like 
products after addition of either particles or nitrite (68).  
Phenolic extracts of clove (Syzygium aromaticum) with novel antioxidant and 
antibacterial activities 
Introduction 
Clove (Syzygium aromaticum) is a rich source of bioactive compounds. The 
goal of this study was to test different extracts of clove in terms of their phenolic 
contents, their antioxidant potential and their antibacterial action against pathogenic 
bacteria. 
Results 
Antioxidant potential of clove extracts was estimated using DPPH  (1,1-
diphenyl-2 picrylhydrazyl), ABTS + 2, 2′azino bis-(3-ethylbenzthiazoline-6-sulfonic 
acid), β-carotene-linoleic bleaching assay and ferric reducing antioxidant power 
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(FRAP). Ethanol and water extracts showed comparable antioxidant activity to the 
synthetic antioxidant tert-butylhydroquinone (TBHQ). The DPPH  radical quenching 
activity varied from 25.3 to 91.4%, while clove extracts showed ABTS +scavenging 
activities from 49.4 to 99.4%. Clove extracts inhibited the bleaching of β-
carotene wherein the order of decreasing activity was water > ethanol > ethyl acetate 
extracts as compared with TBHQ. Clove extracts exhibited antibacterial activities 
against the growth of S. aureus and E.coli in concentration range from 50 to 
100 μg/mL(69).  
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                 4. MATERIALS AND METHODS 
Selection of the Drug: 
For this present study, herbo-mineral formulation of Soodhaga mezhugu was 
taken as a compound drug preparation for Soodhaga vayu has been taken from the 
Siddha classical literature “Kosayee Anuboga Vaithiya Biramma Ragasiyum” written 
by Munusamy mudaliyar. Page No-227(70). 
Ingredients of the drug: 
➢ Vengarathool [Sodium biborate]   
➢ Valendhrapolam [Commiphora myrrha]   
➢ Kunguma poo [Crocus sativus]    
➢ Kirambu thylum [Syzygium aromaticum]   
Collection of the raw materials: 
The raw drugs are Vengarathool, Valendhrapolam and kunguma poo were 
bought from Ramasamy Chetty country shop at Parrys, Chennai. 
Kirambu thylum was prepared from Government Siddha Medical College, 
Pharmacy (Department of Gunpadam), Arumbakkam, Chennai. 
Identification and authentication: 
All raw drugs were identified and authenticated by the experts of Gunapadam 
(Pharmacology) at Government Siddha Medical College, Arumbakkam, and Chennai.   
The specimen samples of the identified raw drugs were preserved in the 
laboratory of P.G Gunapadam for future references. 
Purification: (71) 
Purification process was done as per classical Siddha literature “Gunapadam 
Thathu seeva vaguppu”. 
1.Purification of Vengaram (Sodium biborate): 
Roasted in a pan till the moisture completely evaporates. 
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2. Purification of  Valendhrapolam (Commiphora myrrha) (72): 
 Valendhrapolam is boiled in vinegar steam.   
3. Purification of Kunguma poo (Crocus sativus): 
The unwanted materials are removed. 
4. Purification of Kirambu (Syzygium aromaticum): 
Removed all the impurities and dried it in the sunlight. 
4.1. PREPARATION OF THE SOODHAGA MEZHUGU: 
➢ Vengarathool [ Sodium biborate]   - 975 mg (7 ½ kundri)   
➢ Valendhrapolam [ Commiphora myrrha]  - 780 mg (6 kundri) 
➢ Kunguma poo [ Crocus sativus]   - 205 mg (1 ½ kundri) 
➢ Kirambu thylum [ Syzygium aromaticum]  - 1 drop 
Procedure: 
➢ Purified Vengaram is placed in a stone mortar and ground. Then Kunguma poo 
is added with the above powder and grounded. Purified Valendhrapolam and 
few drops of Kirambu thylum is mixed with the above paste and triturated for 
about 4 hours until get the waxy consistency. The Mezhugu is obtained and 
stored in a closed air tight container. 
Preservation: 
The medicine was preserved in well stoppered air tight glass containers and 
labelled as SM (Soodhaga Mezhugu). 
Drug profile:  
Administration of the drug 
Form of the medicine    - Wax 
Route of administration  - Enteral (Oral) 
Dose        - 0.202 gm (Thuvarai alavu) 
Adjuvant       - Palm jaggery  
Shelf life of the Mezhugu - 5 years 
Indication   - Soodhagha vayu (PCOS). 
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Fig.No.6. Ingredients of Soodhaga Mezhugu: 
 
1.Vengarathool (Sodium biborate): 
 
                          Unpurified                                                 Purified 
 
 
2. Valendhrapolam (Commiphora myrrha): 
 
                       Unpurified                                                 Purified 
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3. Kunguma poo (Crocus sativus): 
       
       
                             Unpurified                                                 Purified 
 
 
4. Kirambu thylum (Syzygium aromaticum): 
                     
Clove oil 
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Fig.No.7. Preparation of Soodhaga Mezhugu: 
Preparation of Soodhaga Mezhugu 
 
 
   
 
 
 
 
 
 
                  Step 1                                                               Step 2 
 
 
Final product of Soodhaga Mezhugu 
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4.2. STANDARDIZATION OF THE SOODHAGA MEZHUGU: 
Standardization of drug means confirmation of its identity, determination of its 
quality, purity and detection of nature of adulterant by various parameters like 
morphological, microscopical, physical, chemical and biological observations. 
Method of standardization: 
Techniques Involved in Standardization of Compound Drugs: 
➢ Macroscopic Methods 
➢ Microscopic Methods  
➢ Physical Methods 
➢ Chemical Methods  
➢ Biological Methods 
4.2.1. ORGANOLEPTIC CHARACTER OF THE SOODHAGA MEZHUGU (73): 
The organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its color, odour, taste, texture etc.  
Colour:  
A sample of Mezhugu was taken in watch glasses and placed against white back 
ground in white tube light. The Mezhugu was observed for its color by naked eye.  
Odour:  
Mezhugu were smelled, the time intermission between two smelling was kept 2 
minutes to nullify the effect of previous smelling.  
Taste:  
A sample of Mezhugu was tasted and the taste was reported.  
Results were noted and tabulated in Table. No:7. 
4.2.2. PHYSICO-CHEMICAL ANALYSIS (74): 
Physico‐chemical studies like total ash, water soluble ash, acid insoluble ash, 
water and alcohol soluble extract, loss on drying at 105°C and pH were done at, Dr. 
MGR University, Chennai.  
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Solubility Test: 
  A few gram of sample (SM) was taken in a dry test tube and to it 2 ml of the 
solvent was added and shaken well for about a minute and the results are observed. The 
test was done for solvents like distilled water, Ethanol, Petroleum ether, Propylene 
glycol, Toluene, Benzene, Chloroform, Ethyl alcohol, Xylene, Carbon tetra chloride 
and the results are observed individually.  
pH value:  
Potentiometrically, pH value is determined by a glass electrode and a suitable 
pH meter. The pH of the Soodhaga mezhugu was written in results column.  
Loss on Drying: 
An accurately weighed 1gm of Soodhaga mezhugu formulation was taken in a 
tarred glass bottle. The crude drug was heated 105°c for 6 hours in an oven till a constant 
weight. The percentage moisture content of the sample was calculated with reference 
to the shade dried material. 
Determination of total Ash: 
Weighed accurately 2g of Soodhaga mezhugu formulation was added in 
crucible at a temperature 600°c in a muffle furnace till carbon free ash was obtained. It 
was calculated with reference to the air-dried drug. 
Determination of acid insoluble ash: 
Ash above obtained was boiled 5min with 25ml of 1M hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffle 
furnace. The percentage of acid insoluble as was calculated with reference to the air-
dried drug. 
Determination of water-soluble ash: 
Total Ash 1g was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with water and ignited for 15 min at a 
temperature not exceeding 450°c in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate. 
MATERIALS AND METHODS 
 
OVULATION INDUCING ACTIVITY OF SOODHAGA MEZHUGU           67 
 
Determination of water-soluble extractive: 
5gm of air-dried drug. Coarsely powered Soodhaga mezhugu was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours, shaking frequently. 
The solution was filtered and 25 ml of filtered was evaporated in a tarred flat bottom 
shallow dish, further dried at 100°c and weighted. The percentage of water-soluble 
extractive was calculated with reference to the air-dried drugs. 
Determination of alcohol soluble extractive: 
1gm of air-dried drugs, coarsely powdered Soodhaga mezhugu was macerated 
with 20ml. Alcohol in closed flask for 24 hours. With frequent shaking.it was filtered 
rapidly talking precaution against loss of alcohol .10ml of filtrate was the evaporated 
in a tarred flat bottom shallow dish, dried at 100°c and weighed. The percentage of 
alcohol soluble extractive was calculated with reference to air dried drug. Results were 
noted and tabulated in Table. No:8. 
4.2.3. PHYTO-CHEMICAL EVALUATION (75): 
Phytochemical are chemical compounds that are naturally present in plants. 
Phytochemical screening of the plant gives a vast idea about the chemical constituents 
present in the drug.  
The SM was subjected to the following phytochemical screening. 
Preparation of the extract 
 The preliminary phytochemical screening test was carried out for each extract 
of Soodhaga mezhugu as per the standard procedures. 
1. Detection of alkaloids: 
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Wagner’s Test: Filtrates were treated with Wagner’s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids. 
2. Detection of Carbohydrates: 
Extracts were dissolved individually in 5ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
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a) Molisch’ Test: To 2ml of plant sample extract, two drops of alcoholic 
solution of α- naphthol are added. The mixture is shaken well and few drops of 
concentrated sulphuric acid is added slowly along the sides of test tube. A violet ring 
indicates the presence of carbohydrates.  
3. Detection of Glycosides: 
 Extracts were hydrolyzed with dil. HCL, and then subjected to test for 
glycosides. 
a) Modified Borntrager’s Test: 
Extracts were treated with Ferric chloride solution was added and immersed in 
boiling water for about 5 minutes. The mixture was cooled and extracted with equal 
volumes of benzene. The benzene layer was again separated and treated with ammonia 
solution. Formation of rose-pink color in the ammoniacal layer indicates the presence 
of anthranol glycosides.  
4. Detection of Saponins: 
a) Foam Test: 0.5 gm of extract was shaken with 2 ml of distilled water. If 
foam produced persists for ten minutes it indicates the presence of saponins. 
5. Detection of Phenols Ferric Chloride Test: 
 Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols.  
6. Detection of Tannins Gelatin Test: 
 The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence of 
phenolic compounds. 
7. Detection of Flavonoids: 
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium 
hydroxide solution. Formation of intense yellow color, which becomes colorless on 
addition of dilute acid, indicates the presence of flavonoids. 
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 8. Detection of Proteins: 
a) Xanthoprotein test: The extracts were treated with few drops of cone. Nitric 
acid. Formation of yellow color indicates the presence of proteins.  
9. Detection of Amino acids: 
a) Ninhydrin Test: To the extract, 0.25% w/v ninhydrin reagent was added and 
boiled for few minutes. Formation of blue color indicates the presence of amino acid. 
10. Detection of Diterpenes Copper Acetate Test: 
 Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes. 
11. Gum and Mucilage: 
 To 1 ml of extract add 2.5 ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicates presence of gum and mucilage. 
12. Test for Quinones: 
 Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones.    
13. Test for Fixed oils and Fats: 
a) Spot Test: A small quantity of extract is pressed between two filter papers. 
Oil stain on the paper indicates the presence of fixed oils. Results were noted and 
tabulated in Table. No:9. 
4.2.4. BIOCHEMICAL ANALYSIS (76): 
The bio-chemical analysis was done to identify the acid and basic radicals 
present in the sample.  
Preparation of extract  
5g of SM was taken in a 250 ml clean beaker and 50 ml of distilled water was 
added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask and 
made up to 100 ml with distilled water. This method is used for the qualitative analysis 
of acidic/basic radicals and biochemical constituents in it. 
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Preliminary Basic and Acidic radical studies  
Preparation of extract 
5gm of SM was weighed accurately and placed in a 250ml clean beaker and 
added with 50ml of distilled water. Then it was boiled well for about 20 minutes. Then 
it was cooled and filtered in a 1000ml volumetric flask and made up to 100ml distilled 
water.   
Table. No.4. Test for basic radicals  
PROCEDURE OBSERVATION INFERENCE 
1.Test for Potassium: A pinch 
of sample is treated with 2ml of 
sodium nitrate solution and then 
treated with 2ml of cobalt nitrate 
in 30% of glacial acetic acid. 
Formation of Yellow 
color precipitate. 
Presence of Potassium. 
2.Test for Calcium: To 2 ml of 
the SM extract 2 ml of 4% 
ammonium oxide solution was 
added.  
Formation of White 
precipitate. 
Presence of Calcium. 
3.Test for Magnesium: To 2ml 
of SM extract, drops of sodium 
hydroxide solution was added. 
Formation of White 
precipitate 
Presence of 
Magnesium. 
4.Test for Ammonium: To 2ml 
of SM extract few ml of Nessler's 
reagent and excess of sodium 
hydroxide solution are added for 
the appearance of brown color. 
Appearance of brown 
color.  
Presence of Ammonium. 
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5. Test for Sodium: 
Hydrochloric acid was added 
with a pinch of the SM sample 
and a paste was made and 
introduced into the blue flame of 
Bunsen burner. 
Appearance of intense 
yellow color 
Presence of Sodium. 
6. Test for Iron (Ferrous): The 
SM extract was treated with 
Conc. HNO3 and ammonium 
thiocyanate. 
Appearance of blood 
red color. 
Presence of Iron. 
7. Test for Zinc: To 2 ml of the 
SM extract drops of sodium 
hydroxide solution was added. 
Formation of White 
precipitate. 
Presence of Zinc. 
8.Test for Aluminium: To the 
2m1 of the SM extract sodium 
hydroxide was added in drops 
and noted. 
White precipitate 
obtained  
Presence of Aluminium. 
9. Test for Lead: To 2 ml of SM 
extract 2ml of potassium iodide 
solution was added and noted. 
Formation of Yellow 
color precipitate. 
Presence of Lead. 
10. Test for Copper: a. A pinch 
of SM sample was made into a 
paste with concentrated. Hcl in a 
watch glass and introduced into 
the non-luminous part of the 
flame and noted.  
b. To 2 ml of SM extract excess 
of ammonia solution was added. 
a & b. Appearance of 
Blue color 
 
 
 
 
Presence of Copper. 
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11. Test for Mercury: To 2m1 
of the SM extract sodium 
hydroxide solution was added. 
Formation of Yellow 
precipitate. 
Presence of Mercury. 
12. Test for Arsenic: To 2 ml of 
the SM extract 2ml of Sodium 
hydroxide solution was added. 
Formation of brownish 
red precipitate 
Presence of Arsenic. 
 
Results were noted and tabulated in Table. No:10. 
 
Table. No.5. Test for acid radicals  
PROCEDURE OBSERVATION INFERENCE 
1. Test for Sulphate: To   2 ml 
of the SM extract 5% of barium 
chloride solution was added. 
Appearance of White 
precipitate. 
Presence of 
Sulphate. 
2. Test for Chloride: The SM 
extract was treated with silver 
nitrate solution and observed.  
Appearance of White 
precipitate. 
Presence of 
Chloride. 
3.Test for Phosphate: The SM 
extract was treated with 
ammonium molybdate and 
concentrated HNO3 and 
observed.  
Appearance of Yellow 
precipitate. 
Presence of 
Phosphate. 
4.Test for Carbonate: The SM 
extract was treated with 
concentrated Hcl and observed. 
for the appearance of 
effervescence. 
Formation of 
effervescence. 
Presence of 
Carbonate. 
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5.Test for Fluoride & 
Oxalate: To 2ml of extract 2ml 
of dil. acetic acid and 2ml 
calcium chloride solution were 
added and heated. 
Formation of cloudy 
appearance. 
Presence of Fluoride 
& Oxalate. 
6. Test for Nitrate: To 1 gm of 
the SM, copper turnings were 
added and again concentrated 
H2SO4 was added, heated and 
the test tube was tilted 
vertically down.  
Characteristic changes.  
 
Presence of Nitrate. 
 
Results were noted and tabulated in Table. No:11. 
The bio-chemical analysis was done to identify the acid and basic radicals 
present in the SM. 
4.2.5. TLC/HPTLC finger print studies (77) 
 HPTLC finger printing was carried out as per the reference. 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
 Vanillin (1g) was dissolved in ice cold ethanol (95ml). Add to 5ml of cooled 
concentrated Sulphuric acid. Ice was added and stirred well. The solution was stored in 
refrigerator. 
Chromatographic conditions 
Instrument    : CAMAG (Switzerland). 
Sample Applicator   : Camag Linomat - IV applicator with N2 gas flow. 
Photo documentation System : Digi store - 2 documentation system with Win Cat 
& Video scan software. 
Scanner   : Camag HPTLC scanner - 3 (030618), Win Cats - IV.  
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Development Chamber  : Camag HPTLC 10X10, 10 X 20 twin trough linear 
Development chamber. 
Quantity applied  : 5, 10 µl for extracts and 5 µl for standards 
Stationary phase   : Aluminum plate pre-coated with silica gel 60(E. Merck) 
Plate thickness   : 0.2 mm. 
Mobile Phase : For Chloroform extract - Toluene: Ethyl acetate (9:1) 
and ethanol extract - Toluene: Ethyl acetate (1:1).   
Scanning wavelength  : 254 nm 
Laboratory condition  : 26 ± 5oC and 53 % relative humidity 
The plate was developed up to a height of 8cm, air dried, spots were observed 
under the UV light at 254 and 366nm. Finally, the plates were derivatized using 
Vanillin-Sulphuric acid reagent heated at 1050 till color spots appeared. Results were 
noted and tabulated in Table. No:12, 13, Graphs. No:1, 2. 
4.2.5. ANTIMICROBIAL ACTIVITY (78):  
AGAR- WELL DIFFUSION METHOD 
The plate count technique is one of the most routinely used procedures because 
of the enumeration of viable cells by this method. 
PRINCIPLE 
The antimicrobials present in the samples are allowed to diffuse out into the 
medium and interact in a plate freshly seeded with the test organisms. The resulting 
zones of inhibition will be uniformly circular as there will be a confluent lawn of 
growth. The diameter of zone of inhibition can be measured in millimeters. 
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MATERIALS REQUIRED 
1. Muller Hinton Agar Medium (1 L) 
The medium was prepared by dissolving 33.8 g of the commercially available 
Muller Hinton Agar Medium (MHI Agar Media) in 1000ml of distilled water. The 
dissolved medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The 
autoclaved medium was mixed well and poured onto 100mm petriplates (25-
30ml/plate) while still molten. 
2. Nutrient broth (1L) 
One litre of nutrient broth was prepared by dissolving 13 g of commercially 
available nutrient medium (HI Media) in 1000ml distilled water and boiled to dissolve 
the medium completely. The medium was dispensed as desired and sterilized by 
autoclaving at 15 lbs pressure (121ºC) for 15 minutes. 
3. Streptomycin (standard antibacterial agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
1. E. coli (ATCC 25922) 
2. Staphylococcus aureus (ATCC 25923) 
3. Pseudomonas aeruginosa (ATCC 27853)  
4. Klebsiella pneumoniae (ATCC 13883) 
PROCEDURE 
Petri plates containing 20ml Muller Hinton Agar Medium were seeded with 
bacterial culture of E. coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and 
Staphylococcus aureus (growth of culture adjusted according to McFarland Standard, 
0.5%). Wells of approximately 10mm was bored using a well cutter and different 
concentrations of sample such as 250μg/mL, 500μg/mL and 1000μg/mL were added. 
The plates were then incubated at 37°C for 24 hours. The antibacterial activity was 
assayed by measuring the diameter of the inhibition zone formed around the well 
(NCCLS, 1993). Streptomycin was used as a positive control. Results were noted and 
tabulated in Table. No:14.1, 14.2, 14.3, 14.4. 
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ANTIFUNGAL ACTIVITY 
AGAR- WELL DIFFUSION METHOD  
PRINCIPLE 
In order to access the biological significance and ability of the sample, the 
antifungal activity was determined by Agar well diffusion method. The antifungals 
present in the samples are allowed to diffuse out into the medium and interact in a plate 
freshly seeded with the test organisms. The resulting zones of inhibition will be 
uniformly circular as there will be a confluent lawn of growth. The diameter of zone of 
inhibition can be measured in millimeters. 
MATERIALS REQUIRED 
1. Potato Dextrose Agar Medium (1 L) 
The medium was prepared by dissolving 39 g of the commercially available Potato 
Dextrose Agar Medium (HiMedia) in 1000ml of distilled water. The dissolved medium 
was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved medium was 
mixed well and poured onto 100mm petriplates (25-30ml/plate) while still molten. 
2.  Clotrimazole (standard antifungal agent, concentration: 10mg / ml) 
3. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
• Aspergillus niger (ATCC 16404)  
PROCEDURE 
Potato Dextrose agar plates were prepared and overnight grown species of 
fungus, Aspergillus niger were swabbed. Wells of approximately 10mm was bored 
using a well cutter and samples of different concentrations such as 250μg/mL, 
500μg/mL and 1000μg/mL were added. The zone of inhibition was measured after 
vernight incubation at room temperature and compared with that of standard 
antimycotic (Clotrimazole) (NCCLS, 1993). Results were noted and tabulated in Table. 
No:14.5. 
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4.2.7. SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT IR - Fourier Transform Infra-red Spectroscopy (79) 
FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications although 
it can also characterize some inorganics. Examples include paints, adhesives, resins, 
polymers, coatings and drugs. FTIR is an effective analytical instrument for detecting 
functional groups. 
Applications: 
➢ Quantative scans 
➢ Qualitative scan solids, liquids, gases 
➢ Organic samples, inorganic samples 
➢ Unknown identification  
➢ Impurities screening 
➢ Formulation 
➢ Pharmaceuticals 
                         
Fig.No.8. FTIR INSTRUMENT 
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Fig.No.9. FT IR MECHANISM 
Principle:  
Spectrophotometric tests are commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures are applicable 
to substances that absorb IR radiation. The IR absorption spectrum of a substance 
compared with that obtained concomitantly for the corresponding reference standard / 
reference substance provide conclusive evidence of the identity of the substance being 
tested.  
 Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›):  
➢ Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. If 
the substance is a hydrochloride it is preferable to use potassium chloride.  
➢ Carefully grind the mixture and spread it uniformly in a suitable die.  
➢ Submit it to the pressure of about 800 mPa (8 tons/cm2).  
➢ Examine the disc visually and if any lack of uniform transparency is observed, 
reject the disc and prepare again.  
➢ Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure.  
➢ When sample and standard are measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% 
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between them (For e.g. If the standard shows a transmittance of 75%, the sample 
transmittance can be between 65% and 85%). 
FT-IR was the most advanced and the major advantage was its 
➢ Speed 
➢ Sensitivity 
➢ Mechanical Simplicity 
➢ Internally Calibrated 
 
Results were noted and tabulated in Table. No:15, Graph. No:3. 
 
ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
     
       Fig.No.10. ICP-OES INSTRUMENT 
 
 Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer 
(ICP). 
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Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are separated 
based on their respective wavelengths and their strengths are measured (spectrometry). 
The intensities are proportional to the concentrations of analyses in the aqueous sample. 
The quantification was an external multipoint linear standardization by comparing the 
emission intensity of an unknown sample with that of a standard sample. Multi-element 
calibration standard solutions are prepared from single- and multi element primary 
standard solutions. With respect to other kinds of analysis where chemical speciation 
was relevant (such as the concentration of ferrous iron or ferric iron), only total essential 
concentration was analyzed by ICP-OES. (80) 
Application: 
The analysis of major and minor elements in solution SM. 
Objectives: 
❖ Determine elemental concentrations of different metals. 
❖ Learn principles and operation of the ICP-OES instrument 
❖ Develop and put on a method for the ICP-OES sample analysis 
❖ Enhance the instrumental conditions for the analysis of different elements 
❖ probes the outer electronic structure of atoms  
Mechanism:  
In plasma emwassion spectroscopy (OES), a SM solution was presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light was collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light was then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison with 
standardization values.(81) 
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The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 
5300 DV.  
 
 
Fig No.11. ICP-OES MECHANISM 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby SM are introduced in liquid form for analysis. 
100 mg SM was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was 
added and mixed well and allowed for few minutes untill the reactions were completed. 
And then, 25 ml of Refined water, was added to prepare digested solution. The digested 
SM solution was shifted into plastic containers and labeled properly. It was completed 
in Bio-chemistry lab, Govt. Siddha Medical College, Chennai-106. Results were noted 
and tabulated in Table. No:16. 
SEM - Scanning Electron Microscope (82): 
Definition: 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
generates high-resolution images and precisely measures very small features and 
objects. 
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SEM analysis applications 
The signals generated during SEM analysis produce a two-dimensional image 
and reveal information about the sample including: 
External morphology (texture) 
➢ Chemical composition (when used with EDS) Orientation of materials making 
up the sample 
The EDS component of the system is applied in conjunction with SEM analysis to: 
➢ Determine elements in or on the surface of the sample for qualitative 
information 
➢ Measure elemental composition for semi-quantitative results 
➢ Identify foreign substances that are not organic in nature and coatings on metal 
SEM Analysis with EDS – qualitative and semi-quantitative results 
Magnification  – from 5x to 300,000x 
Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height 
Materials analyzed – solid inorganic materials including metals and minerals. 
 
Fig.No.12.SEM INSTRUMENT 
MATERIALS AND METHODS 
 
OVULATION INDUCING ACTIVITY OF SOODHAGA MEZHUGU           83 
 
 
Fig.No13.SEM MECHANISM 
 
The SEM analysis process 
Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM microscopy 
applications, data is collected over a selected area of the surface of the sample and a 
two-dimensional image is generated that displays spatial variations in properties 
including chemical characterization, texture and orientation of materials. The SEM is 
also capable of performing analyses of selected point locations on the sample. This 
approach is especially useful in qualitatively or semi-quantitatively determining 
chemical compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into 
an energy spectrum and EDS system software is used to analyze the energy spectrum 
in order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to the 
various elements in the sample. Energy Dispersive X-ray Spectroscopy can be used to 
find the chemical composition of materials down to a spot size of a few microns and to 
create element composition maps over a much broader raster area. Together, these 
capabilities provide fundamental compositional information for a wide variety of 
materials, including polymers. In scanning electron microscope high-energy electron 
beam was focused through a probe towards PP. Variety of signals was produced on 
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interaction with the surface of the sample. This results in the emission of electrons or 
photons and it was collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
➢ Secondary electrons 
➢ back scattered electrons 
➢ characteristic x-rays light 
➢ specimen current 
➢ Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. Results were noted and in Figure.No:17, 18. 
XRD - X-ray Powder Diffraction (XRD) (83) 
X-ray powder diffraction (XRD) is a rapid analytical technique primarily used 
for phase identification of a crystalline material and can provide information on unit 
cell dimensions. The analyzed material is finely ground, homogenized, and average 
bulk composition is determined. 
 
Definition 
 
X-ray powder diffraction is most widely used for the identification of 
unknown crystalline materials (e.g. minerals, inorganic compounds). 
Determination of unknown solids is important to studies in geology, environmental 
science, material science and biology. 
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Fig.No.14. XRD - X-ray Powder Diffraction 
 
 
Fig.No.15. XRD Mechanism 
Applications:  
➢ Characterization of crystalline materials   
➢ Identification of fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically  
➢ Determination of unit cell dimensions.  
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With specialized techniques, XRD can be used to:  
➢ Determine crystal structures using Riveted refinement  
➢ Determine of modal amounts of minerals (quantitative analysis)  
➢ Characterize thin films samples by:  
➢ determining lattice mismatch between film and substrate and to inferring stress 
and strain  
➢ determining dislocation density and quality of the film by rocking curve 
measurements  
➢ measuring super lattices in multilayered epitaxial structures  
➢ determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements  
➢ Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction:   
Strengths:  
➢ Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral  
➢ In most cases, it provides an unambiguous mineral determination  
➢ Minimal sample preparation is required  
➢ XRD units are widely available  
➢ Data interpretation is relatively straight forward.  
Limitations:  
➢ Homogeneous and single-phase material is best for identification of unknown  
➢ Must have access to a standard reference file of inorganic compounds   
➢ Requires tenths of a gram of material which must be ground into a powder  
➢ For mixed materials, detection limit is ~ 2% of sample  
➢ For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated.  
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Sample Collection and Preparation:  
Determination of an unknown requires: the material, an instrument for grinding, and a 
sample holder.  
➢ Obtain a few tenths of a gram (or more) of the material, as pure as possible  
➢ Grind the sample to a fine powder, typically in a fluid to minimize inducing 
extra strain (surface energy) that can offset peak positions, and to randomize 
orientation. Powder less than ~10 µm (or 200-mesh) in size is preferred  
➢ Place into a sample holder or onto the sample surface. 
Results were noted and in Graph. No:4. 
4.3. TOXICOLOGICAL STUDY: 
4.3.1. ACUTE ORAL TOXICITY – OECD GUIDELINES – 423(84)  
➢ Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423) 
➢ The experimental protocol was approved by the institutional ethical committee 
(IAEC) under CPCSEA (IAEC approved Number: 
01/321/PO/Re/S/01/CPCSEA dated 12/10/2018.) 
➢ These studies were conducted in C.L. Baid Metha College of Pharmacy, 
Thoraipakkam, Chennai. 
Introduction: 
➢ The acute toxic class method was stepwise procedure with the use of 3 animals 
of a single sex per step. 
➢ Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity of 
the test substance.  
➢ This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
➢ The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment.  
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➢ In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
➢ The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
➢ The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
PRINCIPLE  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum number of Rats per step; sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental Rats at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three Rats of a single sex. Absence 
or presence of compound-related mortality of the Rats dosed at one step will determine 
the next step, i.e.; − no further testing is needed − dosing of three additional Rats with 
be the same dose − dosing of three additional Rats at the next higher or the next lower 
dose level. The method will enable a judgment with respect to classifying the test 
substance to one of a series of toxicity classes.   
METHODOLOGY 
Selection of Rats 
➢ The animal models used in this study were albino Rats.  
➢ Healthy Female albino Rats weighing 150-250gm were obtained from the 
animal house of Kings Institute, Guindy, Chennai.  
➢ Females should be nulliparous and non-pregnant.  
➢ Each animal must be around 8 and 12 weeks old at the time of dosing.   
➢ The studies were conducted in the animal house of C.L. Baid Metha college of 
Pharmacy, Chennai-97. 
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Housing and Feeding Conditions 
➢ Rats were housed under standard laboratory conditions.  
➢ They were maintained in a ventilated room. The temperature in the room should 
be 22° (±3°).  
➢ The relative humidity should be at least 30% and not exceed 70% (50%-60%). 
➢ Lighting should be artificial; it is maintained as 12h light/dark cycle.  
➢ Rats were kept in a clean polypropylene cage. 
➢ Rats were fed with standard pellet diet (Biogen Foods, Bangalore) and water ad 
libitum.  
Preparation of Rats 
All the Rats were randomly selected and marked on its fur for its individual 
identification. They were acclimatized to the laboratory conditions at least one week 
prior to the commencement of the study.  
Preparation for Acute Toxicity Studies 
Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the Soodhaga mezhugu.  
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design. 
IAEC approved Number :01/321/PO/Re/S/01/CPCSEA dated 12/10/2018. 
Test Substance  : SOODHAGA MEZHUGU 
Animal Source : The animal house of Kings Institute, Guindy,      
Chennai.  
Animals   : Wistar Albino Rats (Female-3+3) 
Age    : 8 to 12weeks 
Body Weight on Day 0 : 150-250gm. 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization 
period. 
Identification of animals : Animals were kept in individual cage and 
numbered. 
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Number of animals  : 3 Female/group,  
Route of administration       : Oral  
Feed and Water : Rodent pellet feed (Sai Meera) purified water    
libitum. 
Housing & Environment : Individually in polypropylene cages 
Housing temperature :  Between 22ºC + 3ºC.    
Relative humidity  :  Between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 48 hours. 
Evaluation   : 14 days. 
EXPERIMENT PROCEDURE  
Administration of doses  
 Soodhaga Mezhugu prepared as per the classical Siddha literature was 
suspended in 2% CMC with uniform mixing and was administered to the groups of 
albino Rats. It is given in a in a single oral dose by gavage using a feeding needle. Rats 
were fasted prior to dosing. Following the period of fasting, the Rats were weighed and 
then the test substance was administered. After the substance has been administered, 
food was withheld for a further 3-4 hours. The principle of laboratory animal care was 
followed. Observations were made and recorded systematically and continuously 
observed as per the guideline after substance administration.  
The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 h prior to the administration of the test suspension. Finally, 
the number of survivors was noted after 24 h and these Animals were then maintained 
for a further 14 days and observations made daily. The toxicological effect was assessed 
on the basis of mortality.  
Number of Animals and dose levels 
Since this test drug has been under practice for long time and likely to be non-
toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried out with 
6 Rats (3 Rats per step). 
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Duration of Study                            :   48 hrs 
Evaluation                                        :   14 Days 
Limit test 
The limit test is primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. A limit test at one dose level of 2000 
mg/kg body weight was carried out with three animals per step. The test substance-
related mortality was not produced in animals, so further testing at the next lower 
level need not be carried out. 
Observations:  
➢ The Animals were observed individually after dosing at least once during the 
first 30mins and periodically during the first 24 hrs. 
➢ Special attention: First 1-4 hrs after administration of drug, and  
➢ It is observed daily thereafter for a total of 14 days, except when they needed 
to be removed from the study and killed humanely for animal welfare reasons 
or are found dead. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 
48.0-hours following drug administration on day 1 of the experiment and daily 
twice thereafter for 14 days. 
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
C. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes, and also 
respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhea, lethargy, sleep and coma. 
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d. Gross necropsy 
           All animals (including those which die during the test period are removed 
from the study) will be subjected to gross necropsy.  Gross necropsy includes 
examination of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents, brain, eye, thymus, lungs, heart, spleen, liver, 
kidneys, adrenals, testes and uterus of all animals. 
Histopathology 
Microscopic examination will be carried out in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the Animals used, 
number of Animals displaying signs of toxicity, the number Animals found dead during 
the test or killed for humane reasons, a description and the time course of toxic effects 
and reversibility, and necroscopic findings. 
Test substance and Vehicle 
 
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing Soodhaga Mezhugu with 2% CMC solution and 
it was found suitable for dose accuracy. 
 
Justification for choice of vehicle (85) 
 
The vehicle selected as per the standard guideline was pharmacologically inert 
and easy to employ for new drug development and evaluation technique. 
Results were noted and tabulated in Table. No:17, 18, 19, 20, 21. 
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4.3.2. REPEATED DOSE 28-DAY ORAL TOXICITY (407) STUDY OF 
SOODHAGA MEZHUGU (86) 
IAEC approved Number :01/321/PO/Re/S/01/CPCSEA dated 12/10/2018. 
Test Substance  : SOODHAGA MEZHUGU 
Animal Source : The animal house of Kings Institute, Guindy, 
Chennai. 
Animals   : Wistar Albino Rats (Male -5, and Female-5) 
Age    : 6-8 weeks 
Body Weight               : 150-300gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization 
period. 
Identification of animals : By cage number, animal number   and    
individual marking by using    Picric acid 
Diet : Pellet feed supplied by Sai Meera foods Pvt Ltd, 
Bangalore. 
Water : Aqua guard portable water in polypropylene 
bottles. 
Housing & Environment : The animals were housed in Polypropylene 
cages provided with bedding of husk. 
Housing temperature :  Between 22ºC + 3ºC.    
Relative humidity  :  Between 30% and 70%, 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Days. 
Justification for Dose Selection: 
The results of acute toxicity studies in albino Rats indicated that Soodhaga 
Mezhugu was non-toxic and no behavioral changes was observed up to the dose level 
of 2000 mg/kg body weight. On the basis of body surface area ratio between Rats and 
human, the doses selected for the study were 100mg/kg, 200 mg/kg and 400 mg/kg 
body weight. The oral route was selected for use because oral route is considered to be 
a proposed therapeutic route. 
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Preparation and Administration of Dose: 
Soodhaga Mezhugu at three doses respectively was suspended in 2 ml of 2% 
CMC in distilled water. It was administered to Rats at the dose levels of 100, 200 and 
400 mg/kg. The test substance suspensions were freshly prepared every day for 28 days. 
The control Rats were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
Methodology 
Randomization, Numbering and Grouping of Animals: 
Ten Rats (Five Male and Five Female) were in each group randomly divided 
into four groups for dosing up to 28 days. Rats were allowed acclimatization period of 
7 days to laboratory conditions prior to the initiation of treatment. Each animal was fur 
marked with picric acid. The females were nulliparous and non-pregnant. 
Table.No.6. Grouping of animals 
 
 
 
 
 
 
 
 
SM – SOODHAGA MEZHUGU 
OBSERVATIONS 
Experimental Rats were kept under observation throughout the course of 
study for the following:  
Body Weight: Weight of each Rats was recorded on day 0, at weekly intervals 
throughout the course of study and at termination to calculate relative organ weights. 
From the data, group mean body weights and percent body weight gain were calculated.  
Groups No of Rats 
Group I Vehicle control  10 (5male,5female) 
Group II SM- low dose 100mg/kg 10 (5male,5 female) 
Group III SM - Mid dose 200mg/kg 10 (5male,5female) 
Group IV SM - High dose 400mg/kg 10(5male,5female) 
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Clinical signs: All Rats were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded. 
Mortality: All Rats were observed twice daily for mortality during entire course of 
study. 
Functional Observations: At the end of the 4th week exposure, ‘sensory reactivity’ to 
graded stimuli of different types (auditory, visual and proprioceptive stimuli), ‘motor 
reactivity’ and ‘grip strength’ were assessed. 
Laboratory Investigations: Following laboratory investigations were carried out on 
day 29 in Rats fasted over-night. Blood samples were collected from orbital sinus using 
sodium heparin (200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for 
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes.  
On 29th day, the Rats were fasted for approximately 18 h, then slightly 
anesthetized with ether and blood samples were collected from the retro-orbital plexus 
into two tubes: one with EDTA for immediate analysis of hematological parameters, 
the other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 
minutes to obtain the serum. Serum was stored at 20 °C until analyzed for biochemical 
parameters. 
Hematological Investigations: Blood samples of control and experimental Rats was 
analyzed for hemoglobin content, total red blood corpuscles (RBC), white blood 
corpuscles (WBC) count and packed cell volume (PCV).  
A Biochemical Investigations: Serum was used for the estimation of biochemical 
parameters. Samples of control and experimental Rats were analyzed for protein, 
bilirubin, urea, BUN, creatinine, triglyceride, cholesterol and glucose levels was carried 
using standard methods. Activities of glutamate oxaloacetate transaminase/ Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino 
transferase (GPT/ALT) and alkaline phosphatase were estimated as per the colorimetric 
procedure.  
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Necropsy: All the Rats were sacrificed on day 29. Necropsy of all Rats was carried out 
and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs 
were recorded. The relative organ weight of each animal was then calculated as follows; 
     Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
    Body weight of animal on sacrifice day (g) 
Histopathology: Histopathological investigation of the vital organs was done. The 
organ pieces (3-5µm thick) of the highest dose level of 400 mg/kg were preserved and 
were fixed in 10% formalin for 24 h and washed in running water for 24 h. Samples 
were dehydrated in an auto Technicon and then cleared in benzene to remove absolute 
alcohol.  Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by the 
“L” molds. It was followed by microtome and the slides were stained with 
Hematoxylin-eosin.  The organs included kidneys, liver, spleen of the Rats were 
preserved they were subjected to histopathological examination. Results were noted 
and in Figure. No:19, 20. 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnett’s multicomparision test using a computer software programme 
GRAPH PAD 8 version. Results were noted and tabulated in Table. No: 22, 23, 24, 25, 
26, 27, 28. 
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4.4. PHARMACOLOGICAL STUDY (87) 
Ovulation inducing activity in female Wister albino rat model  
Animal selection and maintenance 
Species -  Rat 
Strain  -  Wistar albino 
Sex   -  Female  
Age/weight at start of test  -  2 months / 88-130 g 
Acclimatization Period  -  7 days prior to dosing 
Housing -  Individually in polypropylene cages 
Husbandry  -  12-h light/12-h dark artificial photoperiod /   Room 
temperature 22°C (±3°) and relative humidity 30–70% 
Feed and Water -  Rodent pellet feed (Sai Meera) purified water ad libitum 
Identification -  Animals were kept in individual cage and numbered. 
Estimation of hormone level: 
Method   
Before starting drug treatment, the reproductive cycles of the rats were 
synchronized by the following method. 100μg estradiol dissolved in 2 ml olive oil was 
injected subcutaneously. All rats after a 24 hr period, received intramuscular injections 
of 50 μg progesterone dissolved in olive oil. After few hours, vaginal smears were 
obtained by vaginal lavage to monitor ovulation and estrous cycle. Vaginal smears were 
prepared by washing vaginal opening with 0.9% w/v of sodium chloride with a glass 
dropper and placed in a clean glass slide and viewed under light microscope at 40X 
magnification. Examination of vaginal smears showed that all the animals were in the 
estrous stage. (Mar codes FK et al). 
All the animals were weighed daily after drug administration for 10 days. The 
suitable sensitive rats were divided into four groups of six each as follows.  
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Experimental design 
➢ Group I Normal Control animals given only 2ml/kg of CMC solution.  
➢ Group II rats were administered 200mg/kg of Soodhaga Mezhugu for 10days,  
➢ Group III rats were received 400mg /kg of Soodhaga Mezhugu for 10 days  
➢ Group IV received Clomiphene 10mg/kg and served as standard. All the drugs 
were given orally. 
After that 2ml of blood was collected by retro orbital puncture. Blood samples were 
centrifuged for 15 minutes at 4000 rpm and the separated serum samples were frozen 
at -20°C and kept for later estimation of LH, FSH and Estradiol by ELISA method. 
Results were noted and tabulated in Table. No:29 & Chart. No:1. 
4.4.2. Hormonal assay  
Biochemical assay  
The method employed was Microwell Enzyme Linked Immunosorbent Assay 
(ELISA) using analytical grade reagents.  
Estimation of serum luteinizing hormone (LH)  
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml of 
LH-Enzyme reagent was added to all the wells. The microplate was swirled for 20-30 
seconds and covered; this mixture was allowed to incubate for 60 minutes at room 
temperature. After which, the contents were discarded by decantation. 350µl of wash 
buffer was added and decanted for 3 times. 100µl of working substrate solution was 
added to all the wells and was allowed to incubate for fifteen minutes. 50µl of stop 
solution was added to all the wells and gently mixed for 20 seconds. The optical density 
was read at 450nm in a microplate reader within 30mins. The mean absorbance values 
for each set of standards, controls, and test samples were calculated and a standard 
curve was constructed by plotting a mean absorbance obtained from each of the 
reference standard against its concentration from the standard curve. 
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Estimation of serum follicle stimulating hormone (FSH)  
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.050ml of the serum was pipetted into the assigned wells. 0.001ml of 
FSH-Enzyme reagent was added to all the wells. The microplate was swirled for 20-30 
seconds and covered; this mixture was allowed to incubate for 60 minutes at room 
temperature. After which, the contents were discarded by decantation. 350µl of wash 
buffer was added and decanted for 3 times. 100µl of working substrate solution was 
added to all the wells and was allowed to incubate for fifteen minutes. 50µl of stop 
solution was added to all the wells and gently mixed for 20 seconds. The optical density 
was read at 450nm in a microplate reader within 30mins.The mean absorbance values 
for each set of standards, controls, and test samples were calculated and a standard 
curve was constructed by plotting a mean absorbance obtained from each of the 
reference standard against its concentration from the standard curve. 
Determination of serum progesterone levels  
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum was pipetted into the assigned wells. 0.050ml of 
progesterone Enzyme reagent was added to all the wells. The microplate was swirled 
for 20 seconds to mix, 0.050ml progesterone biotin reagent was added to all the wells, 
the mixture was swirled for 20 seconds to mix and covered, this mixture was allowed 
to incubate for 60 minutes at room temperature. After which, the contents were 
discarded by decantation. 350µl of wash buffer was added and decanted for 3 times. 
100µl of working substrate solution was added to all the wells and was allowed to 
incubate for twenty minutes. 50µl of stop solution was added to all the wells and gently 
mixed for 20 seconds. The optical density was read at 450nm in a microplate reader 
within 30mins. The mean absorbance values for each set of standards, controls, and test 
samples were calculated and a standard curve was constructed by plotting a mean 
absorbance obtained from each of the reference standard against its concentration from 
the standard curve.  
Determination of serum Estradiol levels  
The method employed was Microwell immunoassay (ELISA) using analytical 
grade reagents. 0.025ml of the serum reference was pipetted into the assigned wells. 
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0.050ml of Estradiol Biotin reagent was added to all the wells. The microplate was 
swirled for 20 seconds to mix, the mixture was incubated at room temperature for 
30mins,0.050ml Estradiol enzyme reagent was added to all the wells, the mixture was 
swirled for 20 seconds to mix and covered, this mixture was allowed to incubate for 90 
minutes at room temperature. After which, the contents were discarded by decantation. 
350µl of wash buffer was added and decanted for 3 times. 100µl of working substrate 
solution was added to all the wells and was allowed to incubate for twenty minutes. 
50µl of stop solution was added to all the wells and gently mixed for 20 seconds. The 
optical density was read at 450nm in a microplate reader within 30mins. The mean 
absorbance values for each set of standards, controls, and test samples were calculated 
and a standard curve was constructed by plotting a mean absorbance obtained from 
each of the reference standard against its concentration from the standard curve 
Statistical Analysis  
Follicle stimulating hormone, luteinizing hormone, progesterone and estradiol 
measurements are presented as mean ± SEM. One-way Analysis of Variance (ANOVA) 
was used to analyses the data (P<0.05). Results were noted and tabulated in Chart. No:2.
  
4.4.3 ANTI OXIDANT ACTIVITY (88): 
DPPH RADICAL SCAVENGING ASSAY (89) 
  The radical scavenging activity of different extracts was determined by using 
DPPH assay according to Chang et al [2001]. The decrease in the absorption of the 
DPPH solution after the addition of an antioxidant was measured at 517 nm. Ascorbic 
acid (10mg/ml DMSO) was used as reference. 
PRINCIPLE 
1, 1-diphenyl-2-picryl hydrazyl is a stable free radical with pink color which 
turns yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-
A) can be written as,  
                                     DPPH + [H-A] →DPPH-H + (A) 
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Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
REAGENT PREPARATION 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
PROCEDURE 
Different volumes of extracts 1.25μl - 20μl (12.5 - 200µg/ml) from a stock 
concentration 10mg/ml were made up to a final volume of 20µl with DMSO and 1.48ml 
DPPH (0.1mM) solution was added. A control without the test compound, but an 
equivalent amount of distilled water was taken. The reaction mixture incubated in dark 
condition at room temperature for 20 minutes. After 20 minutes, the absorbance of the 
mixture was read at 517nm. 3ml of DPPH was taken as control. 
CALCULATION 
% inhibition =  
Results were noted and tabulated in Table. No:31 & Chart. No: 3. 
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5. RESULTS AND DISCUSSION 
 In this present thesis Soodhagavayu compared to PCOS based on Siddha 
literature. One of the Siddha herbo-mineral formulations, Soodhaga Mezhugu 
mentioned for Soodhagavayu in Siddha literature. The trial drug SM indicated for PCOS 
under the scientific validation through toxicity studies, physicochemical, biochemical 
and pharmacological activity are done to justify the ovulation inducing activity of SM, 
to evaluate the level of FSH, LH, Progesterone, Estradiol and Anti-oxidant activity.  
Literary collections about the drug from various text books give hope about its activity. 
The studies strongly supported the fact through these results. 
They are discussed below: 
The extensive review on botanical aspect gave information about the 
Microscopical, Macroscopical, medicinal uses, constituents and the importance of the 
herbs in detail. Most of the herbs included in the formulation are Anti-bacterial, Anti-
microbial, Anti pyretic and Tonic. 
Discussion on Gunapadam review (90): 
 The Karasaram of Venkaram is very important drug for preparing parpam, 
chendooram and guru. It has an Emmenagogue action and astringent taste. It is useful 
in menstrual related problems. 
 Valendrapolam has a stimulant and Emmenagogue action and bitter taste which 
is helpful in the hormone related problems. 
 Kunkumapoo has a stimulant, anodyne and Emmenagogue action and bitter 
taste. It’s also helpful in menstrual and hormone related problems. 
 Lavangam has a tonic and stimulant action. It is useful in menstrual 
irregularities. 
Discussion on modern drug review: 
Borax is an important, and often underutilized, trace mineral naturally present 
in certain foods and also within the environment. As a mineral that can help balance 
levels of sex hormones in women including estrogen. Boron helps relieve menopause 
symptoms as well as PMS, and also for increasing fertility. In animal studies, boron 
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depletion is linked with fertility problems and birth defects, which suggests that boron 
can play a role in healthy reproduction and fetus development (91).  
 The disease-causing inflammation, Myrrh also appears to support the body in 
reducing disease causing oxidative stress. The antioxidant potential of myrrh is so high 
that it may support healthy liver function. The production of various substances 
necessary for the pituitary gland to release hormones (92). 
 The effects of saffron Crocus sativus on blood level of follicle-stimulating 
hormone (FSH), and number and dynamics of body weight of offspring in female rats 
(93). 
The antioxidant activity of saffron could be attributed to two bioactive 
compounds, crocin and saffranal, and a DPPH radical scavenging test on crocin and 
saffranal exhibited antioxidant activities of 65% and 34%, respectively, at 500 ppm. 
Clove (Syzygium aromaticum) is a rich source of bioactive compounds. The 
goal of this study was to test different extracts of clove in terms of their phenolic 
contents, their antioxidant potential and their antibacterial action against pathogenic 
bacteria(94). 
Discussion of pharmacological review: 
The pharmacological aspect of the review shows the presence of various animal 
models available for PCOS.   
The current pharmacological method available for carrying out the ovulation 
inducing activities were explained clearly and the suitable animals for carrying out the 
activities were discussed to be Wistar albino rats than other animals because of the 
parallelism with the human.  
They are also more sensitive when compared to other animals and hence they 
were chosen for the study.   
The exact ovulogenic activity could never be better studied by analyzing the 
pharmacological activities like Ovulation inducing activity, Antioxidant activity and 
estimation of hormone level in Female Wistar Albino rats.   
Since the three activities could clearly explain whether the drug effectively 
induces ovulation and maintains the level of hormones which gives the knowledge 
about the activities.    
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Discussion on pharmaceutical review 
This review explained the preparation of SM in detail including the purification 
of raw drugs, methods of manufacturing Mezhugu and the Siddha parameters for the 
standardization of Mezhugu analyzing. 
Mezhugu: 
➢ 5 years of shelf life denotes its long-time efficacy. 
➢ Being very fine Micro particles, this micro particle size range helps to attain the 
bio-availability of the drug SM and aid in reaching the target site of action (95).  
Discussion on materials and methods 
The selection of trial drug was taken from the “Kosayee Anuboga Vaithiya 
Biramma Ragasiyum” written by Munusamy mudaliyar.  
The ingredients were bought from the authenticated vender and they were 
identified and authenticated by the experts in Post Graduate Department Gunapadam, 
GSMC, and Chennai. 
The SOP of trial drug was done at the well-equipped lab of the Post Graduate 
Department of Gunapadam. So, the principles of GMP were adhered during process. 
The herbo-mineral formulation Soodhaga Mezhugu had been subjected to 
various studies for its scientific validation and safety assessment. Literary collections, 
physicochemical, biochemical and heavy metal analysis, Toxicological study, 
Pharmacological studies are done to prove its efficacy. 
Organoleptic characters: 
Table No.7. Organoleptic characters of Soodhaga Mezhugu: 
S.No Parameter Result 
1. Colour in day light Yellowish Brown 
2. Odour Pleasant odour 
3. Sense of touch Soft 
4. Appearance Semisolid 
5. Taste Bitter & Astringent 
6. Solubility Soluble in water and alcohol 
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Interpretation: 
 The physical parameters like color, odor, touch, appearance, taste revealed that 
Soodhaga Mezhugu is a Yellowish brown in Color, Soft, Pleasant odor, Bitter & 
Astringent in taste. 
Table.No.8. Results of Physicochemical Parameters 
S.No Parameter Percentage 
1. Specific gravity 0.929 
2. pH 9.07 
3. Particle size Completely passes through sieve no. 125. 
4. 
Loss on drying at 105 degree 
Celsius 
11.32% 
5. Total ash value                                                  42.71%
6. Acid insoluble ash 3.5% 
7. Water soluble ash                                   37.67% 
8. Water soluble extraction 23.2% 
9. Alcohol soluble extraction 8% 
 
Discussion on Physicochemical parameters: 
Solubility: 
➢ Solubility is one of the important parameters to achieve desired concentration 
of drug in systemic circulation for desired (anticipated) pharmacological 
response. 
➢ Oral ingestion is the most convenient and commonly employed route of drug 
delivery due to its ease of administration; oral bioavailability depends on 
solubility (96). 
Discussion:  
SM is soluble in major solvents and sparingly soluble in water, well soluble in 
Hcl, H2SO4. SM proves that its efficiency of solubility increasing the bio availability. 
Specific gravity: 
The trial drug Soodhaga Mezhugu shows low specific gravity (0.929) compared 
to water. This indicates its good nature of absorption of drug. 
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pH value 
 The pH of SM is 9.07. It is alkaline in nature. Our body functions are best when 
the pH is alkaline. Alkaline pH keeps our body tissue supple and reduces inflammation. 
 In our body, the end product of all metabolisms is acids. If our drug also in 
acidic pH causes disturbed homeostasis mechanism. 
 The advantages of alkaline pH (97)  
➢ Decrease aging process 
➢ Alkaline medium enhances the mineral storage in order to buffer  
➢ Increase utilization of oxygen level in body, which reduces fatigue, carry out 
cell repair, enhances ability of mitochondria function  
➢ Also controls infection, inflammation of organs reduces microorganism toxicity 
(Decrease proliferation of microorganism). 
Loss on drying 
Loss on drying value for SM – 11.32% 
➢ Loss on drying (LOD) gives the total amount of volatile content and moisture 
(water) present in the drug.  
➢ The stability of a drug and its shelf-life are dependent on moisture content. 
➢ Being a Mezhugu, the volatile substances are slightly high in SM. 
Ash values 
Total Ash value for SM – 42.71% 
➢ Ash values are helpful in determining the quality and purity of the drugs 
➢ It usually represents the inorganic salts naturally occurring in the drug and 
adhering to it, but it may also include inorganic matter added for the purpose of 
adulteration (98).  
➢ The total ash value of Soodhaga Mezhugu is 42.71%, which determines the 
presence of inorganic content. 
Acid insoluble ash value  
➢ Acid insoluble ash value for SM – 3.5% 
➢ The acid insoluble ash value of the drug denotes the amount of siliceous matter 
present in the plant. The quality of the drug is better if the acid insoluble value 
is low. Acid insoluble ash value of Soodhaga Mezhugu is 3.5%.  
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Water soluble ash value  
Water soluble ash value for SM – 37.67% 
➢ Water soluble ash is a part of total ash value, which denotes the diffusion 
capacity of the drug. 
➢ Here, the water-soluble ash value of SM is 37.67%, which represents easy 
facilitation of diffusion and osmosis mechanism. 
Water-soluble and Alcohol-soluble extraction 
➢ Water-soluble extractive values of ingredients and formulation of Soodhaga 
Mezhugu are depicted in table which shows 23.2%. 
➢ Higher water-soluble extractive value implies that water is a better solvent of 
extraction for the formulation than ethanol. 
➢ Alcohol-soluble extractive values of ingredients and formulation of Soodhaga 
Mezhugu are depicted in table which shows 8%. 
➢ The results of Alcoholic and Water-soluble extracts of the formulation show 
that alkaloids of the formulations are more soluble in water than alcohol and a 
higher water-soluble extractive value of the formulation depicts that water is a 
better solvent of extraction for the formulation than alcohol. 
Phytochemical analysis: 
The phytochemical analysis of Soodhaga Mezhugu result were given below: 
 The preliminary phytochemical studies of aqueous extract of Soodhaga 
Mezhugu were done using standard procedures. The results were presented in tables. 
The present study reveals that the bioactive compounds were present in all the extracts 
of Soodhaga Mezhugu. 
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Table.No:9. Phytochemicals screening test of Soodhaga Mezhugu 
S.No. Phytochemicals Test Name H2O Extract 
1.  Glycoside Modified Borntrager’s Test +ve 
2.  Saponin Foam Test +ve 
3.  Proteins Xanthoprotein Test +ve 
4.  Amino acids Ninhydrin Test +ve 
5.  Diterpenes Copper Acetate Test +ve 
6.  Gum & Mucilage Extract + Alcohol +ve 
+ve/-ve present or absent if component tested 
The above stated phytochemical properties for the given sample certified to be present. 
 
Fig.No.16. Preliminary phytochemical analysis of Soodhaga Mezhugu. 
The Phytochemical analysis of the drug (SM) result reveals Glycoside, Saponin, 
Proteins, Amino acids, Diterpenes, Gum & Mucilage. The interpretation of the result 
was given below. 
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Glycosides: 
➢ Glycosides have antibacterial activity, so they protect our body from bacteria 
and infectious diseases. 
➢ Glycosides increased the intestinal motility. So, it produces laxation (99). 
➢ A glycoside is a molecule consisting of a sugar and a non-sugar molecule, called 
an aglycone. Many biologically active compounds are glycosides. 
➢ The pharmacological effects are largely determined by the structure of the 
aglycone (100). 
Saponins: 
➢ In the digestive tract, saponins produce an emulsification of fat-soluble 
molecules. 
➢ Saponins bind with bile acids and helps to eliminate them from the body, 
preventing cholesterol from being reabsorbed. 
➢ Saponins can boost the immune system, have an antioxidant effect and may 
even support bone strength (101). 
Proteins and Amino acids: 
➢ Lifestyle contributors to disease include not only calorie excess but also the 
dietary intake of specific nutrients. Advanced glycated end-products (AGEs) is 
a class of nutrients incriminated in the pathogenesis of diet-related diseases. 
Cooking or processing at high temperatures such as broiling, grilling, frying and 
roasting is the major source of AGEs. The AGEs promote oxidative stress and 
insulin resistance in peripheral tissues. PCOS women have increased serum 
AGEs levels, and these have been positively correlated with serum androgen 
levels. By activating protein kinase C, AGEs may impair insulin action, thereby 
perpetuating insulin resistance in PCOS. 
Diterpenes: 
➢ Diterpene has an anti-oxidant effect.  
➢ Diterpenes helps to cure hypertension. It also has tumour inhibitory properties 
as well as a stimulating effect on the immune system.  
➢ It is used widely as a stomachic (102). 
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Gum & Mucilage: 
➢ It is used as a bulk laxative. 
➢ Gum and mucilage are used for their demulcent properties for cough 
Suppression (103). 
Bio-Chemical analysis 
Table. No. 10. Results of basic radical studies  
S. No Parameter Result 
1. Test for Potassium Positive 
2. Test for Iron (Ferrous) Positive  
3. Test for Zinc Positive 
4. Test for Aluminum Positive 
 
Table.No.11. Test for acid radical studies 
 
 
 
Discussion on Biochemical analysis 
The Biochemical analysis for basic radicals of SM shows the presence of 
Magnesium, Iron. 
Potassium 
➢ Potassium is very important in cellular biochemical reactions and energy 
metabolism. It participates in the synthesis of protein from amino acids in the 
cell. 
➢ Potassium also functions in carbohydrate metabolism. It is active in glycogen 
and glucose metabolism, converting glucose to glycogen that can be stored in 
the liver for future energy.  
➢ Potassium is important for normal growth and for building muscle (104). 
S.No Parameter Result 
1 Test for Sulphate Positive  
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Iron: 
➢ Iron is used to maintain healthy cells, skin, hair and nails. 
➢ Iron is an essential element for blood production and also production of 
enzymes, hormones, amino acids and neurotransmitter. 
➢ Insufficient amount of iron affects the ovulation. 
➢ Iron separately implicated in the development or protection against disease. 
➢ Health benefits of iron also include the elimination of unexplained or chronic 
fatigue, which may occur in both men and women. Its deficiency is a natural 
cause of fatigue since it is an important component of hemoglobin (105). 
Zinc 
➢ Zinc is a very important element in the reproductive cycle of species. In humans, 
it is necessary for the formation and maturation of spermatozoa, for ovulation 
and for fertilization.  
➢ During pregnancy, zinc deficiency causes a number of anomalies, spontaneous 
abortion, pregnancy-related toxemia, extended pregnancy or prematurity, 
malformations and related growth. Delivery is adversely affected by deficiency.   
➢ These different effects of zinc can be explained by its multiple action on the 
metabolism of androgen hormones, estrogen and progesterone, together with 
the prostaglandins. Nuclear receptors for steroids are all zinc finger proteins. 
➢ Zinc supplementation has already proven beneficial in male sterility and in 
reducing complications during pregnancy. However, it would be worth 
conducting larger-scale trials to confirm these beneficial effects (106). 
➢ Zinc also helps the pituitary gland to release follicle-stimulating hormone 
(FSH). FSH encourages ovulation and tells your ovaries to produce more 
progesterone (107).   
Aluminium 
➢ Aluminum is a great source for various products and compounds that actually 
improve health. 
➢ Aluminum is the third most common element in the earth crust after oxygen and 
silicon. Humans have, in other words, evolved and lived in an aluminum-rich 
environment since the beginning of man. This also means that we’re well 
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adapted to this element and we’re exposed to aluminum in many ways, every 
day (108).  
The biochemical analysis for acidic radicals of SM shows the presence of Sulphate. 
Sulphate 
➢ Sulphate containing proteins work in indirect ways to maintain the hormone 
level. So, it is useful in menstrual irregularities (109). 
The acid basic radical results show presence of Potassium, Zinc, Aluminum, Iron and 
Sulphate which increase the therapeutic effect of SM. 
HPTLC (High Performance Thin Layer Chromatography)  
Sample Name  : Soodhaga Mezhgu 
Stationary Phase  : Silica Gel 60 F254 
Mobile Phase – Toluene : Ethyl acetate: Acetic acid (5: 1.5: 0.15 v/v/v) 
Results of HPTLC study: 
   
 
Table.No.12. HPTLC finger print 
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λ = 254 nm λ = 366 nm λ = 575 nm 
(Derivatized) 
Color Rf 
value(s) 
Color Rf 
value(s) 
Color Rf value(s) 
Color Rf 
value(s) 
Color Rf 
value(s) 
Color Rf value(s) 
Grey 0.14 Blue 0.07 Blue 0.24 
Grey 0.22 Red 0.14 Brown 0.36 
Grey 0.27 violet 0.18 Brown 0.39 
Grey 0.34 Blue 0.22 Yello 
W 
0.51 
Bright 
Blue 
0.40 yellow 0.25 Brown 0.52 
Grey 0.53 Red 0.29 Black 0.65 
Black 0.60 Red 0.35 Violet 0.75 
Grey 0.70 Blue 0.38 Black 0.89 
Blue 0.72 Green 0.44   
Black 0.77 Blue 0.46   
Black 0.85 Blue 0.57   
Black 0.92 Light 
blue 
0.62   
  Bright 
blue 
0.72   
  Red 0.88   
 
Table.No.12a. Results of HPTLC study 
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HPTLC Chromatogram @ 254 nm: 
 
Graph. No.1. HPTLC Chromatogram @ 254 nm 
 
Peak Table @ 254 nm: 
 
Table. No.13. Peak Table @ 254 nm 
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3D Chromatogram @ 254 nm: 
 
 
Graph. No. 2. 3D Chromatogram @ 254 nm  
A qualitative finger printing of Soodhaga mezhugu has been performed by 
HPTLC method, which provides qualitative insights into the bioactive constituents 
present in the drug. HPTLC shows separation of components present in the chloroform 
extract of Soodhaga mezhugu.  
The present study revealed that Soodhaga mezhugu showed best results in 
Toluene: Ethyl Acetate: Acetic Acid 5: 1.5: 0.15 solvent system. After scanning and 
visualizing the plates in absorbance mode at 254nm, 366nm and 575nm and visible 
light range. 
TLC plate showed different colour phytoconstituents of chloroform extract of 
Soodhaga mezhugu. The bands revealed presence of bright blue, greenish blue, violet 
and dark pink, showing the presence of steroids, terpenoids, alkaloids, flavonoids, 
tannins, lignans and saponins. 
The results from HPTLC finger print scanned at wavelength 366nm for 
chloroform extract of Soodhaga mezhugu. There are eleven polyvalent 
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phytoconstituents and corresponding ascending order of Rf values start 0.07 to 0.88 in 
which highest concentrations of the phytoconstituents was found to be 15.19% and 
14.61% with its corresponding Rf value were found to be 0.32 and 0.55 respectively.  
ANTI-MICROBIAL ACTIVITY 
GRAM NEGATIVE 
Table.No.14.1. Organism: E. coli 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Soodhaga Mezhugu 
(SM) 
Streptomycin (100µg) 26 
250 15 
500 17 
1000 20 
14mm-Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
Table.No.14.2. Organism: Klebsiella pneumoniae 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Soodhaga Mezhugu 
(SM) 
Streptomycin (100µg) 25 
250 17 
500 19 
1000 23 
14mm-Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
Table.No.14.3. Organism: Pseudomonas aeroginosa 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Soodhaga Mezhugu 
(SM) 
Streptomycin (100µg) 30 
250 15 
500 19 
1000 24 
14mm-Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
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GRAM POSITIVE 
Table.No.14.4. Organism: Staphylococcus aureus 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Soodhaga Mezhugu 
(SM) 
Streptomycin (100µg) 26 
250 16 
500 18 
1000 21 
14mm-Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
ANTI-FUNGAL ACTIVITY 
Table.No.14.5. Organism: Aspergillus niger 
 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Soodhaga Mezhugu 
(SM) 
Clotrimazole(100µg)  37 
250 17 
500 19 
1000 25 
14mm-Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
 
Inference:  
1. Escherchia.coli   - Highly sensitive in 500(μg/mL) 
2. Klebsiella pneumoniae  - Highly sensitive in 250 (μg/mL) 
3. Pseudomonas aeruginosa  - Highly sensitive in 500(μg/mL) 
4. Staphylococcus aureus  - Highly sensitive in 250 (μg/mL)  
5. Aspergillus niger   - Highly sensitive in 250 (μg/mL) 
Discussion: 
The development of resistance against the presently available antibiotics arises 
the necessity of rediscovery of new anti-bacterial and anti-fungal agents in traditional 
systems of medicine. Different dosages of test drug against the microbes in 
antimicrobial activity of SM was compared with Standard drug Streptomycin and 
Clotrimazole (100μg)/ml disc for the following pathogens, they are Escherchia coli, 
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Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Aspergillus 
Niger. The results represent SM potentially inhibit the growth of all above organism in 
250μl, 500μl and 1000μl / disc. 14 mm – Low sensitive, 15 mm – Moderate, above 16 
mm – Highly sensitive. The findings reveal that the Siddha drug SM have anti-microbial 
potency against bacterial and fungal pathogens which is used in the treatment of 
diseases.  
SOPHISTICATED INSTRUMENTAL ANALYSIS: 
FTIR -FOURIER TRANSFORM INFRARED SPECTROSCOPY 
 
 
Graph. No. 3. FTIR -FOURIER TRANSFORM INFRARED SPECTROSCOPY 
 
Table.No.15. FTIR Interpretation of Soodhaga mezhugu 
 
Absorption peak cm-1 Stretch Functional Group 
3404 
O-H stretch,  
H-bonded 
Alcohols, 
Phenols 
2924 C-H stretch Alkanes 
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2853 C-H stretch Alkanes 
1647 N-H bend 10 amines 
1470 C-H bend Alkanes 
1249 C-O stretch 
Alcohols, carboxylic 
acids, esters, ethers. 
1153 C-H wag (-CH2X) Alkyl halides 
1041 C-N stretch Aliphatic amines 
860 C-Cl stretch Alkyl halides 
558 C-Br stretch Alkyl halides 
Functional groups are structural units within the organic compound that are 
defined by specific bonding arrangements between specific atoms and it means a group 
of atoms the shape of which determines the characteristic chemical properties of the 
molecule.   
The wave numbers from 4000cm-1 to 1500cm-1 gives details for identification 
of functional group. 
The wave number from 1500cm -1 to 400 cm-1 provides particulars about 
molecular fingerprint. 
The FT IR spectra analysis which exhibits the 9 peak value 3404, 2924, 2853, 
1647, 1470, 1249, 1153, 1041, 860, 558cm having O-H stretch, H-bonded, C-H stretch, 
N-H bend, C-H bend, C-O stretch, C-H wag(-CH2X), C-N stretch, C-CI stretch, C-Br 
stretch. 
This peak indicates the presence of functional groups such as Alcohol, Phenols, 
10 Amines, Alkanes, carboxylic acids, esters and ethers, Aliphatic amines, Alkyl 
halides.  
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Alcohol 
➢ The study published in the British Medical Journal (BMJ), suggested that 
drinking in moderation could offer a protective effect for the heart compared 
with not drinking.  
➢ Alcohol in moderation has a reputation for being healthy for the heart. Drinking 
about a glass of wine for women per day, and two glasses for men, in linked to 
a lower risk of heart attack, stroke and death from heart disease. It has anti-
microbial action and acts as an antiseptic agent.  
➢ Alcohol controlling the inflammation and analgesic effect. 
OH 
OH, group of SM has higher potential towards inhibitory activity against 
microorganisms. 
Phenols 
➢ Phenolic compounds are also present in a number of biological systems and 
natural products such as neurotransmitters, flavoring agents, and vitamins to 
name a few. 
➢ The effect of phenols is currently of great awareness due to their anti-oxidative. 
Phenols and flavonoids possess diverse biological activities, for example 
antioxidant and antidepressant activities (110). 
➢ The abnormal oxidative stress in polycystic ovary syndrome (PCOS) could cause 
genetic instability and raise the risk of cancers. Antioxidants have positive 
effects on PCOS. 
Amines: 
➢ Amines are inorganic derivatives of ammonia; they play a very significant role 
in the creating amino acids. 
➢ Amine groups act on the neurotransmitters; and also, it is involved in the protein 
synthesis.  
➢ Proteins are helpful in creation of hormone and enzyme (111). 
Alkanes 
Alkanes are said to be saturated hydrocarbons, because the carbons are bonded 
to the maximum possible number of hydrogen’s - in other words, they 
are saturated with hydrogen atoms (112).   
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Carboxylic acid (113) 
➢ Carboxylic acids make up a series of fatty acids that are extremely good for 
health. The omega-6 and omega-3 fatty acids are considered to be “essential” 
because they are required for good health yet cannot be produced by the body. 
➢ Another name for omega-6 is linoleic acid. It helps to maintain cell membranes 
and to control nutrient use and metabolism and also regulating the hormone 
level. 
➢ Omega 3 fatty acids increase insulin sensitivity, reduce hyperinsulinemia, lower 
plasma triglyceride and liver fat, decrease inflammation and obesity. 
Alkyl halides 
Alkyl halides are also known as haloalkanes. It is required for the synthesis of 
glutathione and anti-oxidant activity.  
ICP-OES (INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROSCOPY): 
 ICP-OES is an analytical technique used for the detection of trace metals. The 
intensity of this emission is indicative of the concentration of the elements within the 
drug SM (wt:0.20350 mg). 
Table.No:16. ICP-OES Interpretation of Soodhaga mezhugu 
 
S.No Elements Wavelength(nm) Concentration 
1. Al 396.152 BDL 
2. As 188.979 BDL 
3. Ca 315.807 21.110mg/L 
4. Cd 228.802 BDL 
5. Cu 327.393 BDL 
6. Fe 238.204 01.054 
7. Hg 253.652 BDL 
8. Mg 285.213 01.224mg/L 
9. Na 589.592 04.321mg/L 
10. Ni 231.604 BDL 
11. Pb 220.353 BDL 
12. P 213.617 58.117mg/L 
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BDL- Below Detecting Limit: 
 1% = 10000 ppm, (1 ppm = 1/1000000 (or) 1 ppm = 0.0001%) 
The toxic metals and the permissible limits 
Heavy metals WHO & FDA limits 
Arsenic (As) 10ppm 
Mercury (Hg) 1ppm 
Lead (Pb) 10ppm 
Cadmium (Cd) 0.3ppm 
 
Interpretation: 
Calcium and phosphorus 
 Calcium (Ca) plays an important role in gonadotropic regulation of ovarian 
steroidogenesis. Marginal deficiency of phosphorus cause disturbance in the pituitary-
ovarian-axis including ovulation. It also suggests that Ca is involved in the distribution 
of cumulus cell cohesiveness by regulating the number of gap junctions between the 
cells, which contributes to the process of ovulation (114).  
Iron  
➢ Iron improves the hematological level in the body and also it is essential for 
growth, reproduction, healing and immune function. 
➢ In this, iron is present in ferrous form, which is soluble and readily absorbed in 
the intestinal lumen.  
Magnesium: 
➢ Magnesium activates over 300 enzyme reactions in the body. 
➢ Magnesium which helps in the hormone creation, it’s a great help to our body. 
➢ Magnesium prevent the excess creation of stress hormone cortisol because of 
excess Cortisol level leads to alteration of progesterone, estrogen, testosterone, 
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FSH and LH will be too, this is the vital when it comes to healing hormonal 
issue like PCOS. 
➢ It helps to maintain nerve and muscle function, supports a healthy immune 
system. 
➢ It also helps regulate blood glucose levels because it enhances insulin secretion 
and aid in the production of energy and protein and facilitates sugar metabolism. 
This is vital when it comes to healing hormonal issues like PCOS. 
➢ Thyroid support – magnesium helps the production of the thyroid hormone and 
as an anti-inflammatory, prevents thyroid diseases. It also prevents the chronic 
urination that can be a sleep interrupter (115). 
Sodium 
Sodium are indirectly related to reproduction. Deficiency of sodium can affect 
the normal reproductive physiology by preventing the utilization of protein and energy. 
So, presence of the minerals enhances the therapeutic effects (116). 
DISCUSSION: 
The result indicate that the formulation is extremely safe as it contains heavy 
metals within specified limits.  
ICP-OES reveals the  concentration of many minerals present in the drug. It also  
has physiologically important minerals like Ca, Fe, Mg, Na & P. In Soodhaga mezhugu, 
the heavy metals like As, Hg, Pb, Cd and trace element like Ni were below detectable 
level. This reveals the safety of the drug. 
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SEM (SCANNING ELECTRON MICROSCOPE) 
The following image is done by 20000X magnification via 2µm aperture shows 
maximum depth focused. 
 
Fig No. 17 Showing micro particles in SEM image of SM(2μm) at 20000 x 
magnification 
 
Fig No. 18 Showing micro particles SEM image of SM(1μm) at 30000 x 
magnification 
The micro particles present in the drug are of great clinical important. Size and 
surface micro particles can be easily manipulated to achieve both passive and active 
targeting. 
Advantages of micro particles in drug delivery system:  
Biodegradable microparticles have been used frequently as drug delivery vehicles 
due to its grand bioavailability, better encapsulation, control release and less toxic 
properties. 
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➢ Increased therapeutic effect of the drug 
➢ Micro particles can be used for directing the drugs to specific target cells 
➢ Decreased toxicity/ side effects 
➢ Protection from physical and chemical degradation  
➢ Improves stability and Increased bioavailability (117). 
The test drug Soodhaga Mezhugu contains Micro particles.  
➢ Micro particles present in the drug results in a better bioavailability and 
facilitate absorption. 
➢ The particles of micro size show that the drug may easily enter the cells at the 
molecular level to treat the disease rapidly and increase the therapeutic effect. 
SEM analysis of the test drug Soodhaga Mezhugu revealed the presence of micro 
particles of size 5-2 Microns. The particles of size micro and near micro size show that 
the drug may easily enter the cells at the molecular level to treat the disease rapidly and 
increase the therapeutic effect. 
XRD (XRAY DIFFRACTION) 
Graph.No.4.XRD Interpretation 
XRD Interpretation 
➢ The X–ray diffraction pattern of a pure substance is, therefore, like a fingerprint 
of the substance. It is based on the scattering of X-ray by crystals. 
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➢ XRD was used to identify drug substance forms and determine the molecular 
structure of the sample. 
➢ It well monitoring the crystal morphology of drugs. 
Results of XRD: 
There are three strongest peaks present in the XRD analysis such as 28.42021, 
46.44214 and 21.54997. 
Discussion on XRD results: 
The crystalline structure, the size and the shape of the particles are highly 
dependent on the route of synthesis and highlight the therapeutic effect of the drug. The 
Nano particles may enhance bio absorption of the drug. 
Any morphological change in the crystalline state of trail drug as a result of the 
manufacturing process can influence a drug’s bioavailability. 
XRD pattern of Soodhaga Mezhugu shows the good crystallinity after 
calcinations process. The major diffraction peaks are identified after XRD analysis SM 
concluded in nano crystalline range (21-46nm) is association with organic molecules 
probably plays an important role in making it biocompatible and nontoxic at therapeutic 
doses. Other elements present in SM act as additional supplement and possibly helps in 
increase the efficacy of the formulation (118).  
 
ACUTE ORAL TOXICITY  
Dose finding experiment and its behavioral Signs of Toxicity for Soodhaga 
Mezhugu.    
Observation done 
Table.No.17. Dose finding experiment and its behavioral Signs of acute oral 
Toxicity 
SL 
Group 
CONTROL 
Observation SL 
Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight 
Normally 
increased 
 
2 Assessments of posture Normal 2 
Assessments of 
posture 
Normal 
3 
Signs of Convulsion 
Limb paralysis 
Normal 3 
Signs of 
Convulsion 
Limb paralysis 
Absence of 
sign (-) 
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4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Normal 
6 Salivation Normal 6 Salivation Normal 
7 Change in skin color 
No significant color 
change 
7 
Change in skin 
color 
No significant 
color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 
Sensitivity 
response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
The animal was observed for 48 hours to watch for twenty parameters, shown in the 
table below. 
Table.No.18. Dose finding experiment and its behavioral Signs of Toxicity of 
SOODHAGA MEZHUGU   
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000mg/kg + - - + - + - - - - - - - - - - - - + - 
(+  Present, -  Absent) 
1. Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response 7.Decreased Motor Activity  8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 
16. Exophthalmos 17. Diarrhoea  18. Writhing   19 Respiration   20.  Mortality 
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Table.No.19. Body weight Observation 
 
 
 
 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table.No.20. Water intake (ml/day) of Wistar albino rats group exposed to                           
Soodhaga Mezhugu: 
DOSE 
 
DAYS 
1 7 14 
CONTROL 58 ± 1.02 58±9.20 59.4±1.04 
HIGH DOSE 
400mg/kg/day 
59.4±2.20 59.8±3.40       59.9±6.24 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table.No.21. Food intake (gm/day) of Wistar albino rats group exposed to 
Soodhaga Mezhugu  
  
        
 
 
 
 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 
CONTROL 220.2±42.30  322.4 ± 60.10 323.6 ±52.10 
HIGH DOSE 
400mg/kg/day 
262.4± 1.21 282 ± 2.04 284.2 ± 2.10 
P value (p)* NS NS NS 
DOSE 
 
DAYS 
1 7 14 
CONTROL 61.04±2.62 62.2±4.76 64.3±6.26 
HIGH DOSE 
400mg/kg/day 
69.4±4.23 70.4±6.22 71.6±4.18 
P value (p)* NS NS NS 
RESULTS AND DISCUSSION 
 
OVULATION INDUCING ACTIVITY OF SOODHAGA MEZHUGU              129 
Acute toxicity Discussion: 
 
➢ Acute oral Toxicity study was done in Rats according to OECD guideline 423. 
The drug was administered at the dose of 2000 mg/kg body weight to two 
groups comprising three Rats in each group. 
➢ It was found that the Rats were alert and responded to touch stimuli, which states 
that the drug did not interfere with the level of consciousness. The study had 
shown that the drug did not produce any impact on central nervous system, 
parasympathetic nervous system, respiratory system. 
SUB-ACUTE TOXICITY OF SOODHAGA MEZHUGU 
REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF SOODHAGA 
MEZHUGU   – (OECD- 407 guidelines) 
Soodhaga Mezhugu at three doses respectively was suspended in 2 ml of 2% 
CMC in distilled water. It was administered to Rats at the dose levels of 100, 200 and 
400 mg/kg. The test substance suspensions were freshly prepared every day for 28 days. 
The control Rats were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
Effect of Soodhaga Mezhugu   on total body weight in Rats 
 The total body weight of the Rats was weighed on 1st, 7th, 14th, 21st, 28th day and 
is shown in the table. It was found that the test drug produced significant weight gain 
than control, with administration of the drug. Similarly, the test drug at all dose levels 
induced weight gain and we could see longer the duration of administration of drug 
higher was the weight gain. 
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Body weight (g) changes of Rats exposed to Soodhaga Mezhugu  
Table.No.22. Body weight of wistar albino rats group exposed to Soodhaga 
Mezhugu  
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 157.02±2.6 159.11±1.86 160.12±2.20 160.84±2.11 162.14±2.81 
100 151.00±1.8 153.25±1.76 149.51±1.86 148.50±1.2 149.50±2.6 
200 150.12±2.92 149.12±1.86 153.28±1.96 155.35±2.01 156.38±1.72 
400 155.37±1.3 153.37±1.32 153.38±1.02 155.12±1.36 156.38±2.6 
P value (p)* NS NS NS NS NS 
NS- Not Significant, **(p < 0.01), *(p <0.05), Values are expressed as mean  
S.E.M. N=10 
Table.No.23. Water intake (ml/day) of Wistar albino rats group exposed to Soodhaga 
Mezhugu    
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 60.1 ± 
8.72 
     60±1.52 60.2±1.40 61±1.32 61.4±1.62 
LOW DOSE 
100mg/kg/day 
65.1±1.21 65.6±4.22 65.2±1.02 65.6±2.06 66.4±1.20 
MID DOSE 
200mg/kg/day 
62.1±1.02 62.3±1.21 63.1±4.62 63.4±1.32 63.4±1.64 
HIGH DOSE 
400mg/kg/day 
64.1±1.81 64.2±1.32 64.4±1.14 64.6±1.62 65.8±2.02 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
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Table No.24. Food intake (gm/day) of Wistar albino rats group exposed to 
Soodhaga Mezhugu 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 34±4.14 34.2±6.12 34.3±2.18 34.2±1.14 34±5.62 
LOW DOSE 
100mg/kg/day 
36.3±1.64 36.4±1.51 36.2±1.51 36.5±1.22 36.5±1.62 
MID DOSE 
200mg/kg/day 
34.1±2.12 34.2±3.50 34.2±2.14 34.2±2.16 35.2±1.64 
HIGH DOSE 
400mg/kg/day 
32.4±1.62 32.4±1.64 33.6±2.36 34.6±1.20 36.4±2.32 
P value (p)* NS NS NS NS NS 
          
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Effect of Soodhaga Mezhugu on Haematological parameters in rats 
 To evaluate the sub-acute toxicity of Soodhaga Mezhugu, the haematological 
parameters like RBC, WBC, platelet, differential count, Hb tests were also executed. 
The above results showed that all parameters remained within normal limits. The rats 
did not reveal any observed signs. 
Table No.25. Effect of Soodhaga Mezhugu   on Haematological parameters in 
rats 
Parameter Control 100mg/kg 200mg/kg 400mg/kg P value 
(p)* 
RBC 
(x 106/mm3) 
5.20.43 5.420.46 6.40.9 6.160.3 
N.S 
PCV (%) 48.21.8 50.21.2 51.30.9 52.60.4* N.S 
Hb (g/dl) 150.3 15.80.6 16.20.4 16.80.9 N.S 
WBC 
(mm3) 
8422183 7780134 8234111* 9147153** 
N.S 
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Neutrophils 
(%) 
182 24.20.19* 24.61.3* 262.12.8** 
N.S 
Mononuclear 
cells (%) 
783 72.211.56 75.60.78 73.22.54 
N.S 
Eosinophils 
(%) 
30.3 2.20.25* 1.80.04** 1.60.07** 
N.S 
Platelets 
(x 103/mm3) 
6456.2 6419.2 6161.5** 6724.3** 
N.S 
 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control;  N=10   
Table No.26. Effect of Soodhaga Mezhugu   on biochemical parameters in rats  
Parameters Control 100mg/kg 200mg/kg 400mg/kg P value 
(p)* 
Albumin (g/dl) 2.80.2 2.150.16 3.140.29 4.340.18** N.S 
Total Cholesterol 
(mg/dl) 
111.5313.17 111.611.8 103.68.6 97.25.96 
N.S 
Triglycerides 
(mg/dl) 
97.5614.5 96.49.8 90.66.8 86.411.2 
N.S 
Glucose (mg/dl) 113.412.2 104.46.8 116.411.3 120.69.5 N.S 
Sodium (mEq/L) 147.35.8 148.66.9 148.94.2 149.35.6 N.S 
Potassium (mEq/L) 5.30.4 4.20.13 4.60.09 5.90.6 N.S 
 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control;  N=10 
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The biochemical parameters are in the reference range and this showed non-
toxic effects on general body metabolism.  
Table.No.27. Renal function test of Wistar albino rats group exposed to 
Soodhaga Mezhugu 
Parameters Control 50mg/kg 200mg/kg 400mg/kg P value 
(p)* 
Urea (mg/dl) 634.3 60.43.4 57.61.6 67.42.4 N.S 
Creatinine 
(mg/dl) 
0.530.03 0.580.04 0.660.11 0.720.06 
N.S 
BUN (mg/dl) 21.334.6 20.42.8 19.61.5 28.60.98** N.S 
 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control;  N=10       
Table.No.28. Liver Function Test of Wistar albino rats group exposed to Soodhaga 
Mezhugu 
Parameters Control 50mg/kg 200mg/kg 400mg/kg P value (p)* 
Total 
Bilirubin 
(mg/dl) 
 
0.90.08 
 
0.640.06 
 
0.830.02* 
 
0.680.09 N.S 
SGOT (U/L) 86.55.0 98.49.8 81.36.5 94.25.8 N.S 
SGPT(U/L) 46.56.2 53.65.6 48.42.9 51.24.2 N.S 
Alkaline 
phosphatase 
(U/L) 
48.67.2 56.45.2 42.33.4 48.64.6 
N.S 
Protein (g/dl) 6.330.3 6.120.5 5.190.28 6.260.15 N.S 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control;  N=10 
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Results for repeated 28 days oral toxicity: 
Observations 
Overall observations were similar in both sex rats. 
Clinical signs of toxicity 
No clinical signs of toxicity were observed. 
Mortality 
No mortality was observed after 28 days repeated dose administration of SM. 
All animals survived to study termination period. 
Body weight 
No significant alterations were observed in body weight. 
Food and water consumption 
No effect of treatment was noted. 
Physiological activities 
No changes in the general behavior. 
Blood analysis 
a. Hematology 
No treatment related effects were observed. 
b. Biological parameters 
No treatment related effects were observed. 
c. Histological examination 
Histological examination of organs did not show any pathological changes. 
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Repeated 28 days oral toxicity Discussion: 
➢ The results of acute toxicity studies in albino Rats indicated that Soodhaga 
Mezhugu was non-toxic and no behavioral changes was observed up to the dose 
level of 2000 mg/kg body weight. On the basis of body surface area ratio 
between Rats and human, the doses selected for the study were 100mg/kg, 200 
mg/kg and 400 mg/kg body weight. The oral route was selected for use because 
oral route is considered to be a proposed therapeutic route. 
➢ No physical changes were observed throughout the dosing period. 
➢ No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits. 
➢ No significant changes in Red blood cells (RBC) white blood cell (WBC), 
packed cell volume (PCV), Erythrocyte sedimentation rate (ESR) in all the 
treated groups as compared to respective control groups. 
➢ Hence the herbo mineral formulation of SM can be considered to be safe drug 
for prolonged duration use as revealed by toxicological studies. 
HISTOPATHOLOGY EXAMINATION 
➢ Histopathology studies were carried out on liver, kidney and spleen and 
recorded. Blood samples for hematological and blood chemical analyses were 
taken from common carotid artery. 
 
➢ All rats were sacrificed after the blood collection. The internal organs and some 
tissues were observed for gross lesions. All tissues were preserved in 10% 
neutral buffered formaldehyde solution for histopathological examination. 
 
Discussion:  
           The above slides show the histopathology studies of repeated 28 days oral 
toxicity studies. There is no toxicological abnormality seen in the vital organs after 
administration of the test drug Soodhaga Mezhugu. Thus, the safety of the drug is 
revealed, so that it can be administered for long time without any side effects. 
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HISTOPATHOLOGY SLIDES: 
Fig.No.19. HISTOPATHOLOGICAL EVALUATION FOR SUB-ACUTE 
TOXICITY 
KIDNEY 
NORMAL     HIGH DOSE 
                       
LIVER 
NORMAL     HIGH DOSE 
                     
SPLEEN 
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PHARMACOLOGICAL STUDY 
         The Soodhaga Mezhugu does not produce any toxic effect on acute and subacute 
oral toxicity. It was conformed that the SM considered being safe at the dose range of 
400 mg/ kg. 
Ovulation inducing activity: 
        Ovulation inducing activity was carried out in 6 Wister albino female rats for each 
group was included in this study. Clomiphene citrate was used as the standard drug, SM 
200 mg/kg and 400 mg/kg were administrated through enteral route. 
Histological analysis:  
      The ovary was separated from the uterus and placed in formalin fixative for 24 
hours. Then these fixed tissue samples were placed in ascending concentrations of 
alcohol and embedded in paraffin. Tissues were sliced with 3-5μm thickness and 
stained with hematoxylin and eosin, and then monitored and analyzed with a light 
microscope. For the evaluation of ovulation inducing activity of trial drug, all tissue 
blocks were serially sliced. Follicle identification was based on the detection of a 
nucleus. The numbers of follicles (primordial, primary, etc.) were counted.  
Discussion on Ovulation inducing activity:  
Histological studies revealed that treatment with doses of 200mg/kg and 
400mg/kg of SM significantly increased the number of primordial follicles (p<0.05 for 
200 mg /kg; p<0.01 for 400 mg /kg;). This increase was also observed in the number of 
primary follicles; however, it was significant only in the 200 mg/kg group (p<0.01). 
And also decreased the number of preantral and antral follicles, 400mg/kg of 
the Soodhaga Mezhugu slightly increased the number of atretic follicles, a greater 
increase was observed at 200mg/kg.  Treatment with doses of 200mg/kg and 400mg/kg 
of Soodhaga Mezhugu significantly increased the number of primary follicles; 
however, it was statistically significant only in the 200mg/kg group. These were more 
prominent in rat ovary that received SM 200mg and Clomiphene citrate. 
SM also caused an increase in the number of atretic follicles, which confirmed 
the containing effect of natural growth of follicles. 
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Effect of Soodhaga Mezhugu on weight of uterus and ovary 
The relative weight of uterus and ovary were significantly increased (P<0.05) 
in test groups that received SM 400mg /kg at the end of the tenth day as compared with 
CMC treated normal female rats. 
Table No.29. Effect of Soodhaga Mezhugu on weight of uterus and ovary after 10 
days treatment 
S.No Group Treatment and dose Weight of 
uterus (mg) 
Weight of 
ovary (g) 
1. Normal 2ml/kg 2% CMC 16.35±1.2 1.690.14 
2. Test-I SM 200mg /kg 12.12±0.57* 1.480.18* 
3. Test-II SM 400mg/kg 14.27±1.01* 1.540.10* 
4. Standard Clomiphene citrate 
10mg/kg 
15.48±+0.72 1.700.12 
      N = 6. Values are expressed as Mean±SEM. *P>0.05 compared to normal control    
Chart. No.1. Effect of Soodhaga Mezhugu on weight of uterus and ovary after 10 
days treatment
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Fig.No.20. Histopathology slides of ovary 
OVARY HISTOPATHOLOGY 
  
 
 
 
 
 
 
Normal      Induced 
 
 
 
 
 
 
 
 
 
 
Low dose       High dose 
 
 
 
Normal control ovary with 
healthy follicles and corpus 
leutum. 
Induced group cystic follicles with thin 
granulosa layer, atretic follicles, stromal 
hyperplasia, and vacuolated stroma. 
 
200mg/kg showing healthy follicles in 
various stages of development and with 
congested blood vessel.  
 
400mg/kg treated showing healthy 
follicle and healthy stroma. 
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Histopathological study of ovary tissue: 
Histological studies of ovarian tissues of normal control group shows ovary 
with healthy follicles and corpus leutum and induced group shows cystic follicles with 
thin granulosa layer, atretic follicles, stromal hyperplasia, and vacuolated stroma. 
Standard group and both doses of Soodhaga Mezhugu (SM –200mg and SM-
400mg) showed some well-defined histological features with showing healthy follicles 
in various stages of development, congested blood vessel and healthy stroma.  
Estimation of hormone level: 
Hormonal Assay 
 The Soodhaga Mezhugu in the dose of 200mg and 400mg was administered 
orally for 10 days and the estimation of LH, FSH, and Progesterone, estradiol study was 
carried out. SM 400mg should significant increase in the hormone level estimated. 
Serum levels of Progesterone and Estradiol were decreased in PCOS induced 
female Wistar rat. Decreased progesterone levels are also an indication of 
anovulation and SM successfully restores the level to normal. Decreased estradiol 
concentration due to inhibition of aromatase in PCOS induced group was significantly 
increased by administration of SM of (400mg/kg). 
Administration of SM in the dose of 200mg/kg and 400mg/kg produced no 
significant effect on LH which was nearly similar to the normal and standard group. 
There was significant increase in the FSH level treated with SM 400mg/kg and the 
200mg/kg was also increase in the level of FSH which was not statistically significant. 
Progesterone level slightly significant compared to the normal and standard 
group. Estrogen level showed significant decreased after the administration of 
Soodhaga Mezhugu at the dose level of 200mg/kg when compared with standard and 
normal control group. Decreased estrogen level was insignificant. But in the dose level 
200 mg/kg significantly increase the estrogen level. 
SM in the dose of 400mg/kg was increase the level of FSH and progesterone 
statistically significant, which is primary step for inducing ovulation.  
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Table No.30. Effect of Soodhaga Mezhugu on Serum Concentration of 
reproductive hormones of female Wister albino rat  
S. 
No 
Group 
Treatment 
and dose 
LH 
(IU/ml) 
FSH  
(IU/ml) 
Estrodial 
(pg/ml) 
Progesterone 
(pg/ml) 
1. Normal 
2ml/kg 2% 
CMC 
0.320.05 0.360.04 62.243.2 8.21.12 
2. Test-I 
SM200mg 
/kg 
0.400.07 0.520.07 
43.25 
2.2**, a 
7.11.00 
3. Test-II SM400mg/kg 0.490.08 
0.62 
0.07* 
38.54 
1.4**,a 
6.70.82 
4. Standard 
Clomiphene 
10mg/kg 
0.560.14 
0.67 
0.10* 
30.62 
1.0** 
6.20.61 
N = 6. Values are expressed as Mean±SEM. *p<0.05;**p<0.01 V Normal 
controla p<0.01 Vs Standard. 
Chart. No.2. Effect of Soodhaga Mezhugu on Serum Concentration of 
reproductive hormones of female Wister albino rat   
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Antioxidant action in PCOS (119): 
 
➢ The abnormal oxidative stress in polycystic ovary syndrome (PCOS) could 
cause genetic instability and raise the risk of cancers. Antioxidants have positive 
effects on PCOS.  
➢ The antioxidants involved in GSH recycling, regulation during the ovarian cycle 
and follicular maturation, oocyte maturation, ovulation, corpus luteum function, 
and steroidogenesis. The possible regulatory function of gonadotropins on 
antioxidants is also addressed here. 
➢ Antioxidant closely related to female subfertility or infertility, oocyte 
maturation to fertilization and embryo development. Elucidation of the 
molecular mechanism underlying the involvement of antioxidants in follicular 
growth, ovarian cycle, oocyte maturation and ovulation is essential to creating 
possible protective effects of antioxidants. 
Result: 
Table.No.31. DPPH assay on Soodhaga Mezhugu 
Concentrations 
(µg/ml) 
 
Absorbance 
 
Percentage of inhibition 
Drug Standard 
 
Drug 
 
 
Standard 
(Ascorbic acid) 
12.5 1.3210 
 
1.4044 9.50 
 
21.90 
25 0.8589 1.0782 27.01 40.04 
50 0.5008 0.7121 43.39 60.40 
100 0.1567 0.2921 55.82 83.75 
200 0.1150 0.0692 67.58 96.15 
*µg/ml: microgram per millilitre. Drug: SM (12.5-200µg/µl). Standard: 
Ascorbic acid (10mg/ml DMSO) 
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Chart.No.3. DPPH assay on Soodhaga Mezhugu 
 
 
Chart no 4: Absorbance of Soodhaga Mezhugu 
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Discussion on Antioxidant activity in DPPH assay:  
DPPH assay were used for the determination of anti-oxidant activity of the 
different extracts. DPPH stable free radical method is an easy, rapid and sensitive way 
to survey the antioxidant activity of SM extract.  The antioxidant molecules can quench 
DPPH free radicals by providing hydrogen atom or by electron donation and a colorless 
stable molecule 1, 1 diphenyl-2- picrylhydrazyl is formed and as a result of which the 
absorbance at 517nm of the solution is decreased.  
In the present study, the SM extract was analyzed to decolorize DPPH and the 
free radical scavenging activity Ascorbic acid (10 mg/ ml DMSO) was used as a 
reference and result was expressed as the percentage decrease in absorbance.  In the 
present study, the extract of SM was found to possess concentration dependent 
scavenging activity on DPPH radicals.  
The values of DPPH free radical scavenging activity of the SM extract were 
given in (Table.No.31) expressed in the percentage. The extract of SM showed the 
highest DPPH scavenging activity (67.58%) at 200µg/ml and the lowest percentage of 
inhibition (9.50%) at 12.5µg/ml.  Ascorbic acid (Standard) showed highest percentage 
of inhibition (96.15%) at 200µg/ml and the lowest percentage of inhibition (21.90%) at 
12.5µg/ml.  
This indicated that % of inhibition increased with increase in concentration of 
both the standard and SM extract. The SM extract has less free radicle scavenging 
activity compared to the standard. From the present study, it was concluded that the SM 
extract has a marked low-level antioxidant activity at higher concentrations. 
Antioxidant capacities of the extracts were expressed in terms of IC50 value of the 
extracts and low IC50 value corresponds to a high antioxidant capacity. 
Hence the in vitro study of DPPH assay free radicle scavenging activity shows 
a less antioxidant property when compared to standard drug ascorbic acid and 
IC50 value (79.9345µg/mL) of the extracts are high in level.  Some other assays have to 
be studied to evaluate the efficacy of antioxidant activity in different assays and in vivo 
studies of SM. This assay confirms that the trial drug SM has significant antioxidant 
property. 
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6. CONCLUSION 
Polycystic ovary syndrome (PCOS) is currently the leading cause of menstrual 
complications in women. There is lot of medications available but it has high cost 
effective and side effects, still need of safe drug with high effectiveness. 
Keeping the aforesaid facts in mind there is a need to provide a solution, this 
study Soodhaga Mezhugu was chosen for PCOS (Soodhaga vayu) from the Siddha 
literature “Kosayee Anuboga Vaithiya Biramma Ragasiyum” written by Munusamy 
mudaliyar as a trial drug which was categorized by the department of AYUSH as a 
classical text. 
The ingredients of the test drug are Vengarathool (Sodium biborate), 
Valendhraholam (Commiphora myrrha), Kunguma poo (Crocus sativus) and Kirambu 
thylum (Syzygium aromaticum). The drugs were identified and authenticated by the 
experts of Gunapadam (Pharmacology), Government Siddha Medical College, 
Chennai-106. 
The drugs were purified and processed as per Siddha literature. The fine 
particles in it enhance the curative potential with shelf life of Five years. 
Organoleptic characters of the SM show GMP based on the Siddha parameters. 
Throughout the study standardization, safety and efficacy were tested thoroughly in the 
following procedures such as physiochemical, phytochemical, biochemical, HPTLC, 
instrument analysis (FTIR, ICPOES, SEM, XRD) Toxicity studies, Pharmacological 
studies.  
In physicochemical analysis SM contain specific gravity, acid soluble ash with 
high total ash value (42.71%) ensure the purity and safety of the drug. Water soluble 
ash value is 37.67% which is a part of total ash value has diffusion capacity of the drug. 
Highly alkaline pH value shows good absorption in alkaline medium (Intestine). Loss 
on drying gives the total of volatile content and moisture present in the drug. The value 
of LOD is 11.32% this ensures maximum stability and better shelf life. The alcoholic 
and water-soluble extracts show that alkaloids are more soluble in water than alcohol. 
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Phytochemical analysis revealed the presence of glycosides, saponin, proteins, 
amino acids, diterpenes, gum and mucilage in the drug and they are responsible for the 
ovulation inducing activity.  
Moreover, the Bio-chemical analysis exhibited the presence of potassium, zinc, 
aluminium, iron and sulphate in the drug which might be responsible for ovulation 
inducing activity and regulating hormone system. The presence of these minerals may 
play an important role in the functioning of various enzymes in biological systems and 
have immunomodulatory functions.  
Soodhaga mezhugu is rich in various Phyto-components that were analysed by 
several qualitative and quantitative analysis. Further, confirmation for the presence of 
Phytosterols like sterols, β-sitosterol etc along with steroid derivatives has been 
performed by HPTLC. 
The anti-microbial and anti-fungal activity shown effective control that at low 
and medium doses against Escherichia coli, Staphylococcus aureus, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Aspergillus niger. 
FTIR shows functional groups such as Alcohol, Phenols, 10 Amines, Alkanes, 
Alcohols, carboxylic acids, esters and ethers, Alkyl halides, Aliphatic amines, Alkyl 
halides, Alkyl halides. Phenolic group of compounds exert antioxidant activity. 
Alcohol, Amines, Alkanes, Carboxylic acid and Alkyl halides which enhance and 
regulate the hormones, have ovulation activity. 
SEM identifies the microparticles in the trail drug. Presence of microparticles 
(5-2 Microns) in medicine increases the drug absorption. Detection of heavy metals in 
the drug through ICP-OES like lead, cadmium, mercury arsenic presents the below 
detective level ensure the safety of the trial drug SM and the presence of Ca, Fe, Mg, 
Na & P. Results of XRD shows crystalline nature of the SM. 
In acute toxicity study single oral dose of the SM showed no mortality of rats 
even under higher dosage levels indicating the high margin of safety of this extract. In 
Repeated 28 days oral toxicity studies results ensure the herbo-mineral formulation of 
SM can be considered to be safe drug for prolonged duration use as revealed by 
toxicological studies. 
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Pharmacological studies had shown that the trial drug increased 
folliculogenesis at the dose level of 400mg/kg and this marked effect was ensured with 
the histological evaluation of uterus of experimental rats also. 
The hormonal assay of the female Wister albino rats was evaluated using the 
estimation of hormones like FSH, LH, Estradiol, Progesterone. Significant increase in 
the hormonal levels of FSH, Progesterone, decrease the LH, estradiol level was 
recorded statistically 400mg/kg of the trail drug. The increase in the level of hormones 
proved to be the prime reason for ovulogenic activity. 
To conclude, the drug Soodhaga Mezhugu beneficiary values for the therapeutic 
efficacy for ovulation, it can be concluded that Soodhaga Mezhugu could be a 
scientifically validated and had shown its sphere of action over the female reproductive 
system especially over the ovaries in the condition called PCOS. 
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     7. SUMMARY 
In this present study the trial drug herbo mineral formulation of Soodhaga 
Mezhugu was taken as the compound drug preparation for Polycystic Ovarian 
Syndrome were taken from the Siddha classical literature “Kosayee Anuboga Vaithiya 
Biramma Ragasiyum” written by Munusamy mudaliyar. 
➢ Selection of the trial drug was approved by the screening committee. 
➢ Introduction of this thesis elucidate about the women’s lifestyle disorders, 
Soodhagavayu compared to the modern aspect PCOS, explain about the signs 
and symptoms, modern treatments. 
➢ Review of literature explain the reference of the trial drug, Gunapadam and 
modern aspect of the drug, disease, treatment and also describe the animal 
model for ovulation inducing activity. 
➢ Systematic identification of trail drug through microscopic and macroscopic 
method and authenticated by Gunapadam department experts. All the 
ingredients in the preparation detoxified and SOP was done at Gunapadam Lab. 
➢ Drug standardization was done through the physicochemical property, acid and 
basic radicles, the functional group and nanoparticles were identified by 
instrumental analysis. 
➢ Toxicological study was made according to OECD guidelines comprising both 
acute and repeated oral dose 28 days toxicity studies in wistar albino rats. It 
showed the safety of the drug which attributes its utility in long time 
administration. 
➢ Pharmacological studies were completed. It discovered the Ovulation inducing 
activity, Estimation of hormone level and Antioxidant activities of Soodhaga 
Mezhugu Results and discussion gives the essential validations to prove the 
potency of the drug.  
➢ Conclusion gives a hoarded form of the study and explains the synergistic effect 
of all the key ingredients and activities that supports the study.   
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8. FUTURE SCOPE 
 Soodhaga Mezhugu indicated for Soodhaga Vayu as per Siddha literature is 
being proved that the drug its role in the treatment of PCOS. 
 With reference to the in vivo studies in Female Wistar Albino rat, clinical trials 
should be conducted in future to authenticate the traditional use of SM in menstrual 
irregularities and fertility issues in humans. 
 SEM depicted the presence of Nano particles, the active compound exhibiting 
the therapeutic efficacy should be analysed. The composition of the compound in micro 
size and their percentage of presence in SM should be elucidated in future by Dynamic 
Light Screening and Nuclear Tracking Analysis. 
 More recently, with the advance of gene technology many new animal models 
that can aid in illumination of PCOS pathophysiology have been established. 
 This is first study where implication of Soodhaga Mezhugu has shown the 
potential to manage PCOS, which could be considered as a novel component for future 
drug development and should be screened for rest of the pharmacological activities like 
Ovulogenic activity, Hormonal assay, Anti-oxidant activity to rule the effective 
pathways so that, the exact benefit and aim of the study would be fulfilled.     
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